###begin article-title 0
Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation
###end article-title 0
###begin p 1
* These authors contributed equally to this work.
###end p 1
###begin p 2
###xml 339 346 339 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(SPTLC1</italic>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 411 420 411 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 444 450 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKBKAP</italic>
###xml 670 684 670 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR (p75/NTR)</italic>
###xml 771 794 771 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1, RAB7, WNK1/HSN2</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 925 930 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 935 944 935 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 1085 1089 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1256 1262 1256 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 1405 1409 1405 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 1411 1415 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 1420 1424 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 811 819 <span type="species:ncbi:9606">patients</span>
###xml 1119 1127 <span type="species:ncbi:9606">patients</span>
###xml 1496 1503 <span type="species:ncbi:9606">patient</span>
Hereditary sensory and autonomic neuropathies (HSAN) are clinically and genetically heterogeneous disorders characterized by axonal atrophy and degeneration, exclusively or predominantly affecting the sensory and autonomic neurons. So far, disease-associated mutations have been identified in seven genes: two genes for autosomal dominant (SPTLC1 and RAB7) and five genes for autosomal recessive forms of HSAN (WNK1/HSN2, NTRK1, NGFB, CCT5 and IKBKAP). We performed a systematic mutation screening of the coding sequences of six of these genes on a cohort of 100 familial and isolated patients diagnosed with HSAN. In addition, we screened the functional candidate gene NGFR (p75/NTR) encoding the nerve growth factor receptor. We identified disease-causing mutations in SPTLC1, RAB7, WNK1/HSN2 and NTRK1 in 19 patients, of which three mutations have not previously been reported. The phenotypes associated with mutations in NTRK1 and WNK1/HSN2 typically consisted of congenital insensitivity to pain and anhidrosis, and early-onset ulcero-mutilating sensory neuropathy, respectively. RAB7 mutations were only found in patients with a Charcot-Marie-Tooth type 2B (CMT2B) phenotype, an axonal sensory-motor neuropathy with pronounced ulcero-mutilations. In SPTLC1, we detected a novel mutation (S331F) corresponding to a previously unknown severe and early-onset HSAN phenotype. No mutations were found in NGFB, CCT5 and NGFR. Overall disease-associated mutations were found in 19% of the studied patient group, suggesting that additional genes are associated with HSAN. Our genotype-phenotype correlation study broadens the spectrum of HSAN and provides additional insights for molecular and clinical diagnosis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">1993</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">1993</xref>
###xml 936 941 936 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2003</xref>
###xml 223 231 <span type="species:ncbi:9606">Patients</span>
###xml 779 787 <span type="species:ncbi:9606">patients</span>
Hereditary sensory and autonomic neuropathies (HSAN) are a clinically and genetically heterogeneous group of inherited peripheral neuropathies, primarily affecting the peripheral sensory and autonomic neurons (Dyck, 1993). Patients usually exhibit prominent distal sensory loss with manifest insensitivity to pain in some. The prominent distal sensory loss frequently leads to chronic ulcerations in feet and hands, sometimes resulting in severe complications such as extensive soft tissue infections, osteomyelitis necessitating amputations of toes and fingers or, in rare instances, even of more proximal parts of the extremities (Dyck, 1993). Autonomic dysfunction, such as anhidrosis, fever, blood pressure fluctuations and gastro-intestinal disturbances are present in some patients. Electrophysiologically, axonal nerve damage of the sensory neurons is often found, but additional demyelination may also be present (Auer-Grumbach et al., 2003).
###end p 4
###begin p 5
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">1993</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">2004</xref>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 489 494 489 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">2006<italic>a</italic></xref>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
HSAN can be transmitted as an autosomal dominant (AD) or autosomal recessive (AR) trait. Isolated patients have also been described (Dyck, 1993; Auer-Grumbach, 2004). The AD types of HSAN usually present in the second or third decade of life with marked sensory involvement and minimal autonomic and variable motor involvement, while AR HSAN present either as congenital syndromes with striking sensory and autonomic abnormalities or as almost pure autonomic disorders (Verpoorten et al., 2006a).
###end p 5
###begin p 6
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">1993</xref>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">1996</xref>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 727 728 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 723 728 723 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">2006<italic>a</italic></xref>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">1995</xref>
A classification of the hereditary sensory neuropathies into types HSAN I-V (Dyck, 1993) was made based on age at onset, inheritance pattern and additional features. Although the clinical classification of these HSAN types is based on a small number of individuals, it still stands after the molecular characterization of the subtypes in recent years. There is variable motor involvement in the AD form of HSAN, making the distinction with hereditary motor and sensory neuropathies (HMSN) or Charcot-Marie-Tooth disease (CMT) difficult. In CMT2B, sensory loss and the associated ulcerations are such prominent phenotypic features that inclusion within the HSAN-spectrum is justified (Vance et al., 1996; Verpoorten et al., 2006a). However, due to the concomitant motor involvement with distal muscle atrophy and weakness, this phenotype was originally classified as HMSN (Kwon et al., 1995).
###end p 6
###begin p 7
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">2001</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">2001</xref>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2006</xref>
###xml 474 483 474 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 650 655 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">2004</xref>
###xml 942 948 942 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKBKAP</italic>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">2001</xref>
###xml 1039 1044 1039 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 1173 1178 1173 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1181 1185 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">1996</xref>
###xml 1360 1364 1360 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 1380 1385 1380 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1388 1392 1388 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">2004</xref>
###xml 1406 1411 1406 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 1431 1436 1431 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1439 1443 1439 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">2001</xref>
###xml 1458 1463 1458 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1466 1470 1466 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">2004</xref>
###xml 1615 1620 1615 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1623 1627 1623 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">2003</xref>
###xml 1673 1678 1673 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1685 1686 1685 1686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1681 1686 1681 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">2006<italic>b</italic></xref>
###xml 1782 1783 1782 1783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1802 1808 1802 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(CCT5)</italic>
###xml 1820 1825 1820 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1832 1833 1832 1833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1828 1833 1828 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">2006<italic>a</italic></xref>
###xml 2081 2086 2081 2086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2089 2093 2089 2093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">2006</xref>
So far, seven genes have been identified for the different types of HSAN (). Two genes have been associated with AD HSAN: missense mutations in serine palmitoyltransferase long chain subunit 1 (SPTLC1) are found in families and individuals with HSAN type I, an adult-onset sensory neuropathy (Bejaoui et al., 2001; Dawkins et al., 2001). Mutations in the small GPTase late endosomal protein RAB7, cause CMT2B (Verhoeven et al., 2003; Meggouh et al., 2006). Mutations in the WNK1/HSN2 gene [protein kinase with-no-lysine(K)-1/hereditary sensory neuropathy type 2] cause AR HSAN type II, an early-onset ulcero-mutilating sensory neuropathy (Lafreniere et al., 2004). HSAN type III, also known as Familial Dysautonomia or Riley-Day syndrome, presents with typical prominent autonomic manifestations early in life and is caused by mutations in the inhibitor of kappa-light polypeptide gene enhancer in B cells, kinase complex associated protein (IKBKAP) (Slaugenhaupt et al., 2001). Mutations in neurotrophic tyrosine kinase, receptor type 1 (NTRK1) are reported in families with congenital insensitivity to pain, anhidrosis and mental retardation (CIPA or HSAN type IV) (Indo et al., 1996). HSAN type V, a phenotype closely related to CIPA but with normal mental development and less pronounced anhidrosis, can be caused by mutations in nerve growth factor beta (NGFB) (Einarsdottir et al., 2004) but also by NTRK1-mutations (Houlden et al., 2001; Einarsdottir et al., 2004). Apart from these six HSAN subtypes other forms with distinct additional features exist, e.g. HSAN with gastroesophageal reflux and cough (Kok et al., 2003) and HSAN with spastic paraplegia (Bouhouche et al., 2006b). Recently, the gene for this last form has been identified as cytosolic chaperonin-containing t-complex peptide-1 (CCT5) (Bouhouche et al., 2006a). The identification of causative genes for the HSAN forms in recent years has provided preliminary insights in the pathogenesis of these rare neuropathies although the fundamental underlying pathomechanisms still remain to be unveiled (Verhoeven et al., 2006).
###end p 7
###begin p 8
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKBKAP</italic>
###xml 731 735 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 808 815 808 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p75/NTR</italic>
###xml 895 900 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">1992</xref>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
In this study, we investigated a cohort of 100 familial and isolated patients who had a clinical diagnosis compatible with any of the subtypes of HSAN listed above, and we determined the contribution of mutations in the known genes associated to the distinct phenotypes. IKBKAP was not screened since our cohort did not contain patients with familial dysautonomia. The cohort included 16 index patients of families that have previously been reported in manuscripts describing novel genes and related phenotypes. We broadened the screening of the individual genes to non-associated phenotypes in order to establish potential new genotype-phenotype correlations. Furthermore, we performed the first large-scale mutation screening of WNK1 and CCT5. Additionally, we screened the functional candidate gene NGFR (p75/NTR) because of its importance in development and function of sensory neurons (Lee et al., 1992).
###end p 8
###begin title 9
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and Methods
###end title 9
###begin title 10
Selection criteria
###end title 10
###begin p 11
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">1993</xref>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">2006</xref>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 812 816 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">1996</xref>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 837 842 837 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">2006<italic>a</italic></xref>
###xml 2199 2204 2199 2204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2207 2211 2207 2211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">2000</xref>
###xml 2227 2232 2227 2232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2235 2239 2235 2239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2003</xref>
###xml 2270 2274 2270 2274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">2007</xref>
###xml 64 71 <span type="species:ncbi:9606">patient</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 672 680 <span type="species:ncbi:9606">patients</span>
###xml 944 952 <span type="species:ncbi:9606">patients</span>
###xml 1230 1238 <span type="species:ncbi:9606">patients</span>
###xml 1313 1321 <span type="species:ncbi:9606">patients</span>
###xml 2128 2136 <span type="species:ncbi:9606">patients</span>
###xml 2288 2296 <span type="species:ncbi:9606">patients</span>
For this study, we selected a group of 100 individuals from our patient database. These were individuals presenting with a clinical phenotype compatible with any of the HSAN subforms described earlier (Dyck, 1993; Auer-Grumbach et al., 2006). The majority of patients presented with progressive distal sensory loss, often associated with one or several of the following additional features: skin changes (e.g. hyperkeratosis, ulcerations), spontaneous fractures, amputations and autonomic features. Because variable motor involvement under the form of distal muscle wasting and weakness can be present in some subtypes of sensory neuropathies, we also included a group of patients diagnosed with CMT2B, a variant of axonal motor and sensory neuropathy (HMSN II), with prominent ulcero-mutilations (Vance et al., 1996; Verpoorten et al., 2006a). To avoid inclusion of classic axonal CMT variants unrelated to the HSAN spectrum, we only included patients with motor and sensory neuropathies if their clinical presentation was complicated by the development of ulcerations. Overall, the cohort in this study could be described as a group of hereditary ulcero-mutilating and sensory neuropathies. Autonomic symptoms were only seen in patients who also presented with sensory abnormalities. Our cohort did not contain patients with predominant or pure dysautonomia, the hallmark feature of HSAN type III or Riley-Day syndrome. Diagnosis was based on clinical presentation, complemented with nerve conduction velocity (NCV) measurements and EMG. No strict electrophysiological selection criteria were applied to our cohort, given the broad range of electrophysiological features associated with the various HSAN phenotypes. Typically, a predominantly sensory axonal neuropathy was found, which was often more severe in the lower limbs. Occasional electrophysiological signs of demyelination can also be found in HSAN. Electrophysiological abnormalities in motor nerves such as reduced amplitudes of compound muscle action potentials and slightly reduced motor NCV can be found, illustrating the overlap between HSAN and HMSN. In CIPA patients, nerve conduction studies can be within normal range (Shatzky et al., 2000; Auer-Grumbach et al., 2003; Axelrod and Gold-von Simson, 2007). In several patients, nerve and skin biopsies were performed.
###end p 11
###begin title 12
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient cohort
###end title 12
###begin p 13
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 577 585 <span type="species:ncbi:9606">patients</span>
###xml 640 645 <span type="species:ncbi:9606">child</span>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
###xml 839 847 <span type="species:ncbi:9606">patients</span>
###xml 1029 1037 <span type="species:ncbi:9606">patients</span>
###xml 1053 1061 <span type="species:ncbi:9606">patients</span>
###xml 1132 1140 <span type="species:ncbi:9606">patients</span>
###xml 1209 1217 <span type="species:ncbi:9606">patients</span>
###xml 1276 1284 <span type="species:ncbi:9606">patients</span>
###xml 1335 1343 <span type="species:ncbi:9606">patients</span>
###xml 1386 1394 <span type="species:ncbi:9606">patients</span>
###xml 1439 1447 <span type="species:ncbi:9606">patients</span>
###xml 1623 1631 <span type="species:ncbi:9606">patients</span>
###xml 1647 1655 <span type="species:ncbi:9606">patients</span>
###xml 1774 1782 <span type="species:ncbi:9606">patients</span>
###xml 2189 2197 <span type="species:ncbi:9606">patients</span>
The cohort consisted of 100 index patients who were referred to our laboratory for molecular genetic testing in the context of HSAN. Genomic DNA samples were provided through Neurologic and Paediatric Departments and Neuromuscular Centres worldwide. The majority of samples were of European origin. In 43 patients, autonomic features were noted, 44 had a pure sensory neuropathy and the remaining 13 were diagnosed as sensory-motor neuropathy with ulcero-mutilations. In two patients, the HSAN phenotype presented with an associated spastic paraplegia. For 21 out of 100 index patients, a dominant inheritance pattern, based on a parent to child transmission, could be determined. For eight index patients, a recessive inheritance pattern characterized by the presence of affected siblings in the pedigree could be determined. Twenty-four patients were referred as 'isolated' since they did not have a familial history of neuropathy in the first- and second-degree relatives. No family history was available for the remaining 47 patients. In five index patients, there was a clear indication of consanguinity of the parents. For 44 patients, detailed information about the age at onset was available; in nine patients, first symptoms occurred in the first year of life, in 11 patients the disease started in the first decade and in 12 patients in the second decade. In the remaining 12 patients, onset was after the age of 20 years. In 35 patients, ulcerations were present and 17 out of them displayed additional complications such as osteomyelitis or amputations. Detailed electrophysiological data were available for 37 patients, the remaining patients had an electrophysiological evaluation by their referring physician but detailed information was not available. In 17 patients, a nerve biopsy or a combined sural nerve/muscle biopsy was performed showing abnormalities compatible with a diagnosis of HSAN. All referring clinicians were neurologists, orthopaedic surgeons or paediatricians active in the field of rare neuromuscular diseases and well acquainted with the clinical presentation of HSAN and related phenotypes. The referring clinicians obtained informed consent from all patients or their legal representatives prior to enrolment in this study.
###end p 13
###begin title 14
Molecular genetic analysis
###end title 14
###begin p 15
All DNA samples were amplified using the whole genome amplification kit 'GenomiPhi V2 DNA Amplication Kit' (GE Healthcare, Waukesha, USA). The protocol was performed according to the manufacturer's instruction.
###end p 15
###begin p 16
###xml 94 130 94 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1, RAB7, WNK1/HSN2, NTRK1, NGFB</italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">2000</xref>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">2004</xref>
###xml 799 804 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 807 811 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">2005</xref>
###xml 1014 1020 1003 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 1035 1039 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1054 1059 1043 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 1074 1078 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 1093 1097 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 1112 1116 1101 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 1158 1167 1147 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 1233 1237 1222 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
The coding regions and exon-intron boundaries up to 100 bp up- and downstream of the exons of SPTLC1, RAB7, WNK1/HSN2, NTRK1, NGFB, CCT5 and NGFR were PCR-amplified using primer oligonucleotides designed with the Primer3 and SNPbox software tools (Rozen and Skaletsky, 2000; Weckx et al., 2004). PCR conditions are available upon request. PCR products were cleaned up using the Exonuclease I-Shrimp Alkaline Phosphatase enzyme (USB, Cleveland, USA). Mutation screening was performed by direct sequencing of the purified PCR fragments using the BigDye(R) Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, USA). Fragments were separated on an ABI3730xl DNA Analyser (Applied Biosystems, Foster City, USA). The resulting sequences were aligned and analysed with the novoSNP (Weckx et al., 2005) and SeqMantrade markII (DNASTAR Inc., Madison, USA) programs. The nucleotide numbering of the genes is relative to the ATG translation initiation site with A as +1 of the corresponding cDNA sequences (SPTLC1: NM_006415.2; RAB7: NM_004637.5; NTRK1: NM_002529.3; NGFB: NM_002506.2; CCT5: NM_012073.3; NGFR: NM_002507). The nucleotide numbering of WNK1/HSN2 is relative to the first nucleotide of the HSN2-specific exon of WNK1 (NM_213665.1). Mutations are described according to the latest conventions on the nomenclature of DNA sequence variants (). Sequence variants were confirmed by repeated PCR on original DNA samples and bidirectional sequencing. Where possible, segregation of the mutation with the disease phenotype was analysed in the family.
###end p 16
###begin title 17
Genotyping and paternity testing
###end title 17
###begin p 18
Paternity was tested using 15 highly informative short tandem repeats (STRs) distributed throughout the genome (ATA38A05, D1S1646, D1S1653, D1S1360, D2S2256, D3S3037, D4S2382, D4S3240, D7S509, D8S1759, D9S1118, D12S1056, D12S2082, D16S2619 and GATA152H04). STRs were PCR-amplified and PCR fragments were loaded on an ABI3730xl DNA Analyser. Genotypes were analysed using Local Genotype Viewer, a software program developed in-house ().
###end p 18
###begin title 19
Analysis of exon skipping
###end title 19
###begin p 20
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 450 457 <span type="species:ncbi:9606">patient</span>
Analysis of exon skipping was performed by RT-PCR on mRNA isolated from lymphoblast cell lines of patients CMT-841.01 and CMT-886.01. mRNA was first purified from peripheral blood lymphoblasts using the RNeasy mini kit (Qiagen, Hilden, Germany). DNA inactivation was performed using the Turbo DNA free kit (Ambion, Austin, USA) and subsequently analysed for splicing defects by RT-PCR and sequencing using exonic primers located in exons 1 and 5 for patient CMT-886.01 (forward: 5'-CTGCTGGCTTGGCTGATACT-3', reverse: 5'-CACTGCAGCTTCTGTTCAGG-3') and exonic primers in exons 12 and 16 for CMT-841.01 (forward: 5'-CCTTGTGCTCAACAAATGTGG-3', reverse: 5'-AGCCAGCAGCTTGGCAT-3') (Superscript III First-Strand Synthesis System for RT-PCR; Life Technologies, San Diego, USA).
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 117 136 117 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1, RAB7, NTRK1</italic>
###xml 141 150 141 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 370 378 370 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Tables 1</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 386 393 386 393 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</label>
###xml 393 448 393 448 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="23">Clinical features of HSAN patients with proven mutation</p>
###xml 393 448 393 448 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="23">Clinical features of HSAN patients with proven mutation</p></caption>
###xml 448 455 448 455 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Patient</th>
###xml 455 459 455 459 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene</th>
###xml 459 468 459 468 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AA change</th>
###xml 468 474 468 474 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Origin</th>
###xml 474 483 474 483 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Diagnosis</th>
###xml 483 494 483 494 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Inheritance</th>
###xml 494 497 494 497 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AAO</th>
###xml 497 500 497 500 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SAO</th>
###xml 500 503 500 503 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ALE</th>
###xml 503 515 503 515 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sensory loss</th>
###xml 515 527 515 527 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Skin changes</th>
###xml 527 538 527 538 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Amputations</th>
###xml 538 556 538 556 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Bone complications</th>
###xml 556 574 556 574 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Autonomic symptoms</th>
###xml 448 574 448 574 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">AA change</th><th rowspan="1" colspan="1">Origin</th><th rowspan="1" colspan="1">Diagnosis</th><th rowspan="1" colspan="1">Inheritance</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">SAO</th><th rowspan="1" colspan="1">ALE</th><th rowspan="1" colspan="1">Sensory loss</th><th rowspan="1" colspan="1">Skin changes</th><th rowspan="1" colspan="1">Amputations</th><th rowspan="1" colspan="1">Bone complications</th><th rowspan="1" colspan="1">Autonomic symptoms</th></tr>
###xml 448 574 448 574 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">AA change</th><th rowspan="1" colspan="1">Origin</th><th rowspan="1" colspan="1">Diagnosis</th><th rowspan="1" colspan="1">Inheritance</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">SAO</th><th rowspan="1" colspan="1">ALE</th><th rowspan="1" colspan="1">Sensory loss</th><th rowspan="1" colspan="1">Skin changes</th><th rowspan="1" colspan="1">Amputations</th><th rowspan="1" colspan="1">Bone complications</th><th rowspan="1" colspan="1">Autonomic symptoms</th></tr></thead>
###xml 574 584 574 584 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-186.05</td>
###xml 584 590 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 584 590 584 590 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>SPTLC1</italic></td>
###xml 590 599 590 599 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ala352Val</td>
###xml 599 606 599 606 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Austria</td>
###xml 606 611 606 611 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN1</td>
###xml 611 613 611 613 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 613 616 613 616 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">16y</td>
###xml 616 637 616 637 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sensory abnormalities</td>
###xml 637 640 637 640 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">46y</td>
###xml 640 649 640 649 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe LL</td>
###xml 649 650 649 650 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 650 651 650 651 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;</td>
###xml 651 652 651 652 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;</td>
###xml 652 653 652 653 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;</td>
###xml 574 653 574 653 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ala352Val</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN1</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">16y</td><td rowspan="1" colspan="1">Sensory abnormalities</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Severe LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td></tr>
###xml 653 663 653 663 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-791.01</td>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 663 669 663 669 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>SPTLC1</italic></td>
###xml 669 678 669 678 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser331Phe</td>
###xml 678 692 678 692 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">France (Gypsy)</td>
###xml 692 701 692 701 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN/CIPA</td>
###xml 701 703 701 703 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 703 707 703 707 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">cong</td>
###xml 707 728 707 728 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 728 730 728 730 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">7y</td>
###xml 730 795 730 795 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe loss of superficial touch distal LL, insensitivity to pain</td>
###xml 795 821 795 821 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">eschar and ulceration foot</td>
###xml 821 822 821 822 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 822 823 822 823 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 823 849 823 849 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gastro- oesophageal reflux</td>
###xml 653 849 653 849 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ser331Phe</td><td rowspan="1" colspan="1">France (Gypsy)</td><td rowspan="1" colspan="1">HSAN/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Severe loss of superficial touch distal LL, insensitivity to pain</td><td rowspan="1" colspan="1">eschar and ulceration foot</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Gastro- oesophageal reflux</td></tr>
###xml 849 858 849 858 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PN-626.01</td>
###xml 858 862 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 858 862 858 862 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 862 871 862 871 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Val162Met</td>
###xml 871 878 871 878 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Belgium</td>
###xml 878 883 878 883 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 883 885 883 885 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 885 888 885 888 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">37y</td>
###xml 888 906 888 906 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis toes</td>
###xml 906 909 906 909 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">54y</td>
###xml 909 923 909 923 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Diminished L&gt;R</td>
###xml 923 939 923 939 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes</td>
###xml 939 947 939 947 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (toes)</td>
###xml 947 972 947 972 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis in the toes</td>
###xml 972 973 972 973 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 849 973 849 973 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">37y</td><td rowspan="1" colspan="1">Osteomyelitis toes</td><td rowspan="1" colspan="1">54y</td><td rowspan="1" colspan="1">Diminished L&gt;R</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the toes</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 973 982 973 982 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-90.01</td>
###xml 982 986 982 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 982 986 982 986 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 986 995 986 995 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Val162Met</td>
###xml 995 997 995 997 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UK</td>
###xml 997 1002 997 1002 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1002 1004 1002 1004 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1004 1007 1004 1007 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">28y</td>
###xml 1007 1023 1007 1023 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes</td>
###xml 1023 1026 1023 1026 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">64y</td>
###xml 1026 1091 1026 1091 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe in distal LL, position sense conserved, UL less pronounced</td>
###xml 1091 1107 1091 1107 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes</td>
###xml 1107 1126 1107 1126 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (all toes R foot)</td>
###xml 1126 1129 1126 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 1129 1130 1129 1130 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 973 1130 973 1130 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">UK</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">28y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">64y</td><td rowspan="1" colspan="1">Severe in distal LL, position sense conserved, UL less pronounced</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (all toes R foot)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1130 1140 1130 1140 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-126.01</td>
###xml 1140 1144 1140 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1140 1144 1140 1144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 1144 1153 1144 1153 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Leu129Phe</td>
###xml 1153 1160 1153 1160 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Austria</td>
###xml 1160 1165 1160 1165 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1165 1167 1165 1167 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1167 1170 1167 1170 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">15y</td>
###xml 1170 1184 1170 1184 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Weakness in LL</td>
###xml 1184 1187 1184 1187 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">75y</td>
###xml 1187 1193 1187 1193 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe</td>
###xml 1193 1209 1193 1209 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations feet</td>
###xml 1209 1210 1209 1210 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1210 1237 1210 1237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis and -necrosis</td>
###xml 1237 1238 1237 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1130 1238 1130 1238 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Weakness in LL</td><td rowspan="1" colspan="1">75y</td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1238 1248 1238 1248 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-140.01</td>
###xml 1248 1252 1248 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1248 1252 1248 1252 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 1252 1261 1252 1261 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Leu129Phe</td>
###xml 1261 1268 1261 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Austria</td>
###xml 1268 1273 1268 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1273 1275 1273 1275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1275 1278 1275 1278 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">13y</td>
###xml 1278 1294 1278 1294 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes</td>
###xml 1294 1297 1294 1297 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">46y</td>
###xml 1297 1305 1297 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Moderate</td>
###xml 1305 1332 1305 1332 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations and foot callus</td>
###xml 1332 1340 1332 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (toes)</td>
###xml 1340 1367 1340 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis and -necrosis</td>
###xml 1367 1368 1367 1368 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1238 1368 1238 1368 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">13y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Ulcerations and foot callus</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1368 1378 1368 1378 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-186.26</td>
###xml 1378 1382 1378 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1378 1382 1378 1382 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 1382 1391 1382 1391 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Leu129Phe</td>
###xml 1391 1398 1391 1398 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Austria</td>
###xml 1398 1403 1398 1403 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1403 1405 1403 1405 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1405 1408 1405 1408 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">20y</td>
###xml 1408 1424 1408 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes</td>
###xml 1424 1427 1424 1427 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">49y</td>
###xml 1427 1455 1427 1455 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe in LL (toes and feet)</td>
###xml 1455 1471 1455 1471 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes</td>
###xml 1471 1472 1471 1472 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1472 1499 1472 1499 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis and -necrosis</td>
###xml 1499 1500 1499 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1368 1500 1368 1500 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">49y</td><td rowspan="1" colspan="1">Severe in LL (toes and feet)</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1500 1510 1500 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-186.28</td>
###xml 1510 1514 1510 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1510 1514 1510 1514 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 1514 1523 1514 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Val162Met</td>
###xml 1523 1530 1523 1530 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Austria</td>
###xml 1530 1535 1530 1535 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1535 1537 1535 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1537 1540 1537 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">15y</td>
###xml 1540 1553 1540 1553 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Steppage gait</td>
###xml 1553 1556 1553 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">34y</td>
###xml 1556 1580 1556 1580 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No clinical sensory loss</td>
###xml 1580 1604 1580 1604 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Multiple ulceration toes</td>
###xml 1604 1635 1604 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (lower leg L, several toes R)</td>
###xml 1635 1648 1635 1648 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis</td>
###xml 1648 1649 1648 1649 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1500 1649 1500 1649 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Steppage gait</td><td rowspan="1" colspan="1">34y</td><td rowspan="1" colspan="1">No clinical sensory loss</td><td rowspan="1" colspan="1">Multiple ulceration toes</td><td rowspan="1" colspan="1">+ (lower leg L, several toes R)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1649 1659 1649 1659 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-195.01</td>
###xml 1659 1663 1659 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1659 1663 1659 1663 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 1663 1672 1663 1672 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Val162Met</td>
###xml 1672 1675 1672 1675 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">USA</td>
###xml 1675 1680 1675 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1680 1682 1680 1682 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1682 1684 1682 1684 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ad</td>
###xml 1684 1701 1684 1701 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gait disturbances</td>
###xml 1701 1704 1701 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 1704 1713 1704 1713 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL</td>
###xml 1713 1729 1713 1729 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations feet</td>
###xml 1729 1732 1729 1732 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 1732 1735 1732 1735 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 1735 1736 1735 1736 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1649 1736 1649 1736 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">USA</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">ad</td><td rowspan="1" colspan="1">Gait disturbances</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1736 1746 1736 1746 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-178.01</td>
###xml 1746 1750 1746 1750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 1746 1750 1746 1750 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>HSN2</italic></td>
###xml 1750 1763 1750 1763 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ile355AsnfsX7</td>
###xml 1763 1770 1763 1770 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Belgium</td>
###xml 1770 1775 1770 1775 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN2</td>
###xml 1775 1777 1775 1777 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 1777 1780 1777 1780 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;2y</td>
###xml 1780 1819 1780 1819 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations hand and feet, poor healing</td>
###xml 1819 1821 1819 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5y</td>
###xml 1821 1872 1821 1872 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td>
###xml 1872 1900 1872 1900 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations toes and fingers</td>
###xml 1900 1901 1900 1901 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1901 1945 1901 1945 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Spontaneous fractures LL + Charcot atropathy</td>
###xml 1945 1946 1945 1946 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1736 1946 1736 1946 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Ile355AsnfsX7</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;2y</td><td rowspan="1" colspan="1">Ulcerations hand and feet, poor healing</td><td rowspan="1" colspan="1">5y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations toes and fingers</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Spontaneous fractures LL + Charcot atropathy</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 1946 1956 1946 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-260.01</td>
###xml 1956 1960 1956 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 1956 1960 1956 1960 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>HSN2</italic></td>
###xml 1960 1967 1960 1967 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gln184X</td>
###xml 1967 1974 1967 1974 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Austria</td>
###xml 1974 1979 1974 1979 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN2</td>
###xml 1979 1981 1979 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 1981 1984 1981 1984 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">inf</td>
###xml 1984 2027 1984 2027 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Clumsiness hands, osteomyelitis in the foot</td>
###xml 2027 2030 2027 2030 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">50y</td>
###xml 2030 2081 2030 2081 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td>
###xml 2081 2092 2081 2092 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations</td>
###xml 2092 2112 2092 2112 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (fingers and toes)</td>
###xml 2112 2137 2112 2137 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis in the foot</td>
###xml 2137 2138 2137 2138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 1946 2138 1946 2138 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Gln184X</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">inf</td><td rowspan="1" colspan="1">Clumsiness hands, osteomyelitis in the foot</td><td rowspan="1" colspan="1">50y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations</td><td rowspan="1" colspan="1">+ (fingers and toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the foot</td><td rowspan="1" colspan="1">&#8211;</td></tr>
###xml 2138 2148 2138 2148 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-451.04</td>
###xml 2148 2152 2148 2152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 2148 2152 2148 2152 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>HSN2</italic></td>
###xml 2152 2182 2152 2182 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pro85ProfsX14 + Gln364SerfsX16</td>
###xml 2182 2187 2182 2187 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Italy</td>
###xml 2187 2192 2187 2192 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN2</td>
###xml 2192 2194 2192 2194 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 2194 2197 2194 2197 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;1y</td>
###xml 2197 2230 2197 2230 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Difficulties in hand manipulation</td>
###xml 2230 2233 2230 2233 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">33y</td>
###xml 2233 2284 2233 2284 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td>
###xml 2284 2313 2284 2313 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ulcerations in hands and feet</td>
###xml 2313 2375 2313 2375 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (progressive spontaneous amputations hands, and LL to knees)</td>
###xml 2375 2407 2375 2407 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Painless pathologic fractures LL</td>
###xml 2407 2410 2407 2410 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 2138 2410 2138 2410 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Pro85ProfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;1y</td><td rowspan="1" colspan="1">Difficulties in hand manipulation</td><td rowspan="1" colspan="1">33y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations in hands and feet</td><td rowspan="1" colspan="1">+ (progressive spontaneous amputations hands, and LL to knees)</td><td rowspan="1" colspan="1">Painless pathologic fractures LL</td><td rowspan="1" colspan="1">Unk</td></tr>
###xml 2410 2420 2410 2420 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-179.01</td>
###xml 2420 2425 2420 2425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 2420 2425 2420 2425 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 2425 2439 2425 2439 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gly181GlyfsX16</td>
###xml 2439 2446 2439 2446 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Belgium</td>
###xml 2446 2456 2446 2456 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 2456 2458 2456 2458 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 2458 2462 2458 2462 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">cong</td>
###xml 2462 2487 2462 2487 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Delayed motor milestones?</td>
###xml 2487 2490 2487 2490 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">12y</td>
###xml 2490 2511 2490 2511 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 2511 2540 2511 2540 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Thickening and ulcerations LL</td>
###xml 2540 2541 2540 2541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 2541 2542 2541 2542 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 2542 2552 2542 2552 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis</td>
###xml 2410 2552 2410 2552 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gly181GlyfsX16</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Delayed motor milestones?</td><td rowspan="1" colspan="1">12y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Thickening and ulcerations LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis</td></tr>
###xml 2552 2562 2552 2562 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-197.01</td>
###xml 2562 2567 2562 2567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 2562 2567 2562 2567 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 2567 2596 2567 2596 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.359+ 5G&gt;T aberrant splicing</td>
###xml 2596 2603 2596 2603 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Belgium</td>
###xml 2603 2613 2603 2613 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 2613 2615 2613 2615 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 2615 2618 2615 2618 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;8m</td>
###xml 2618 2640 2618 2640 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Fever of unknown cause</td>
###xml 2640 2643 2640 2643 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">14y</td>
###xml 2643 2664 2643 2664 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 2664 2667 2664 2667 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 2667 2668 2667 2668 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 2668 2669 2668 2669 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 2669 2695 2669 2695 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis, fever episodes</td>
###xml 2552 2695 2552 2695 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.359+ 5G&gt;T aberrant splicing</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;8m</td><td rowspan="1" colspan="1">Fever of unknown cause</td><td rowspan="1" colspan="1">14y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr>
###xml 2695 2705 2695 2705 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-366.01</td>
###xml 2705 2710 2705 2710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 2705 2710 2705 2710 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 2710 2719 2710 2719 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Arg761Trp</td>
###xml 2719 2734 2719 2734 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The Netherlands</td>
###xml 2734 2744 2734 2744 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 2744 2746 2744 2746 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 2746 2750 2746 2750 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">cong</td>
###xml 2750 2785 2750 2785 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis, hyperthermia, hypotonia</td>
###xml 2785 2787 2785 2787 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3y</td>
###xml 2787 2808 2787 2808 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 2808 2811 2808 2811 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 2811 2812 2811 2812 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 2812 2845 2812 2845 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Painless fracture right calcaneus</td>
###xml 2845 2871 2845 2871 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis, fever episodes</td>
###xml 2695 2871 2695 2871 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg761Trp</td><td rowspan="1" colspan="1">The Netherlands</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Anhidrosis, hyperthermia, hypotonia</td><td rowspan="1" colspan="1">3y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Painless fracture right calcaneus</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr>
###xml 2871 2881 2871 2881 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-826.01</td>
###xml 2881 2886 2881 2886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 2881 2886 2881 2886 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 2886 2917 2886 2917 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.2046+ 3 A&gt;C aberrant splicing</td>
###xml 2917 2922 2917 2922 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Spain</td>
###xml 2922 2932 2922 2932 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 2932 2934 2932 2934 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR</td>
###xml 2934 2936 2934 2936 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5m</td>
###xml 2936 2952 2936 2952 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Skin ulcerations</td>
###xml 2952 2955 2952 2955 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">20y</td>
###xml 2955 2992 2955 2992 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain and temperature</td>
###xml 2992 3019 2992 3019 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Hyperkeratosis, ulcerations</td>
###xml 3019 3027 3019 3027 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (toes)</td>
###xml 3027 3040 3027 3040 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Osteomyelitis</td>
###xml 3040 3066 3040 3066 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis, fever episodes</td>
###xml 2871 3066 2871 3066 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.2046+ 3 A&gt;C aberrant splicing</td><td rowspan="1" colspan="1">Spain</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Skin ulcerations</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Insensitivity to pain and temperature</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr>
###xml 3066 3076 3066 3076 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-841.01</td>
###xml 3076 3081 3076 3081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 3076 3081 3076 3081 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 3081 3090 3081 3090 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Arg565Gln</td>
###xml 3090 3123 3090 3123 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td>
###xml 3123 3133 3123 3133 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 3133 3142 3133 3142 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR (cons)</td>
###xml 3142 3147 3142 3147 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">4 yrs</td>
###xml 3147 3185 3147 3185 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Painless tibial fracture, poor healing</td>
###xml 3185 3188 3185 3188 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">35y</td>
###xml 3188 3209 3188 3209 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 3209 3210 3209 3210 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 3210 3211 3210 3211 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 3211 3295 3211 3295 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Multiple factures (pelvic bone, upper and lower limbs and foot bones), osteomyelitis</td>
###xml 3295 3305 3295 3305 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis</td>
###xml 3066 3305 3066 3305 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg565Gln</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR (cons)</td><td rowspan="1" colspan="1">4 yrs</td><td rowspan="1" colspan="1">Painless tibial fracture, poor healing</td><td rowspan="1" colspan="1">35y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Multiple factures (pelvic bone, upper and lower limbs and foot bones), osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis</td></tr>
###xml 3305 3315 3305 3315 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PN-1192.03</td>
###xml 3315 3320 3315 3320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 3315 3320 3315 3320 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 3320 3333 3320 3333 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gln626GlnfsX7</td>
###xml 3333 3366 3333 3366 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td>
###xml 3366 3376 3366 3376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 3376 3385 3376 3385 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC (cons)</td>
###xml 3385 3389 3385 3389 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">cong</td>
###xml 3389 3427 3389 3427 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Hypotonia, recurrent episodes of fever</td>
###xml 3427 3429 3427 3429 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2y</td>
###xml 3429 3450 3429 3450 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 3450 3553 3450 3553 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Keratodermatitis, xerodermia, selfmutilation of fingers and tongue, necrotizing fasciitis of right hand</td>
###xml 3553 3554 3553 3554 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 3554 3555 3554 3555 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 3555 3573 3555 3573 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis, fevers</td>
###xml 3305 3573 3305 3573 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gln626GlnfsX7</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC (cons)</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Hypotonia, recurrent episodes of fever</td><td rowspan="1" colspan="1">2y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Keratodermatitis, xerodermia, selfmutilation of fingers and tongue, necrotizing fasciitis of right hand</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fevers</td></tr>
###xml 3573 3583 3573 3583 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-886.01</td>
###xml 3583 3588 3583 3588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 3583 3588 3583 3588 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 3588 3630 3588 3630 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">c.354_359+3 delTCGCCTGAA aberront splicing</td>
###xml 3630 3636 3630 3636 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Turkey</td>
###xml 3636 3646 3636 3646 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN4/CIPA</td>
###xml 3646 3648 3646 3648 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IC</td>
###xml 3648 3650 3648 3650 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5m</td>
###xml 3650 3677 3650 3677 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Fever, recurrent infections</td>
###xml 3677 3679 3677 3679 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">7y</td>
###xml 3679 3700 3679 3700 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insensitivity to pain</td>
###xml 3700 3774 3700 3774 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Hyperkeratosis, ulcerations, nail dystrophy, automutilations, neck abscess</td>
###xml 3774 3775 3774 3775 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 3775 3804 3775 3804 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Avascular necrosis left talus</td>
###xml 3804 3814 3804 3814 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anhidrosis</td>
###xml 3573 3814 3573 3814 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.354_359+3 delTCGCCTGAA aberront splicing</td><td rowspan="1" colspan="1">Turkey</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Fever, recurrent infections</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations, nail dystrophy, automutilations, neck abscess</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Avascular necrosis left talus</td><td rowspan="1" colspan="1">Anhidrosis</td></tr>
###xml 574 3814 574 3814 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ala352Val</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN1</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">16y</td><td rowspan="1" colspan="1">Sensory abnormalities</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Severe LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td></tr><tr><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ser331Phe</td><td rowspan="1" colspan="1">France (Gypsy)</td><td rowspan="1" colspan="1">HSAN/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Severe loss of superficial touch distal LL, insensitivity to pain</td><td rowspan="1" colspan="1">eschar and ulceration foot</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Gastro- oesophageal reflux</td></tr><tr><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">37y</td><td rowspan="1" colspan="1">Osteomyelitis toes</td><td rowspan="1" colspan="1">54y</td><td rowspan="1" colspan="1">Diminished L&gt;R</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the toes</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">UK</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">28y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">64y</td><td rowspan="1" colspan="1">Severe in distal LL, position sense conserved, UL less pronounced</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (all toes R foot)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Weakness in LL</td><td rowspan="1" colspan="1">75y</td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">13y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Ulcerations and foot callus</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">49y</td><td rowspan="1" colspan="1">Severe in LL (toes and feet)</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Steppage gait</td><td rowspan="1" colspan="1">34y</td><td rowspan="1" colspan="1">No clinical sensory loss</td><td rowspan="1" colspan="1">Multiple ulceration toes</td><td rowspan="1" colspan="1">+ (lower leg L, several toes R)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">USA</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">ad</td><td rowspan="1" colspan="1">Gait disturbances</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Ile355AsnfsX7</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;2y</td><td rowspan="1" colspan="1">Ulcerations hand and feet, poor healing</td><td rowspan="1" colspan="1">5y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations toes and fingers</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Spontaneous fractures LL + Charcot atropathy</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Gln184X</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">inf</td><td rowspan="1" colspan="1">Clumsiness hands, osteomyelitis in the foot</td><td rowspan="1" colspan="1">50y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations</td><td rowspan="1" colspan="1">+ (fingers and toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the foot</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Pro85ProfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;1y</td><td rowspan="1" colspan="1">Difficulties in hand manipulation</td><td rowspan="1" colspan="1">33y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations in hands and feet</td><td rowspan="1" colspan="1">+ (progressive spontaneous amputations hands, and LL to knees)</td><td rowspan="1" colspan="1">Painless pathologic fractures LL</td><td rowspan="1" colspan="1">Unk</td></tr><tr><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gly181GlyfsX16</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Delayed motor milestones?</td><td rowspan="1" colspan="1">12y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Thickening and ulcerations LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis</td></tr><tr><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.359+ 5G&gt;T aberrant splicing</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;8m</td><td rowspan="1" colspan="1">Fever of unknown cause</td><td rowspan="1" colspan="1">14y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg761Trp</td><td rowspan="1" colspan="1">The Netherlands</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Anhidrosis, hyperthermia, hypotonia</td><td rowspan="1" colspan="1">3y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Painless fracture right calcaneus</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.2046+ 3 A&gt;C aberrant splicing</td><td rowspan="1" colspan="1">Spain</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Skin ulcerations</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Insensitivity to pain and temperature</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg565Gln</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR (cons)</td><td rowspan="1" colspan="1">4 yrs</td><td rowspan="1" colspan="1">Painless tibial fracture, poor healing</td><td rowspan="1" colspan="1">35y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Multiple factures (pelvic bone, upper and lower limbs and foot bones), osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis</td></tr><tr><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gln626GlnfsX7</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC (cons)</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Hypotonia, recurrent episodes of fever</td><td rowspan="1" colspan="1">2y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Keratodermatitis, xerodermia, selfmutilation of fingers and tongue, necrotizing fasciitis of right hand</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fevers</td></tr><tr><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.354_359+3 delTCGCCTGAA aberront splicing</td><td rowspan="1" colspan="1">Turkey</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Fever, recurrent infections</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations, nail dystrophy, automutilations, neck abscess</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Avascular necrosis left talus</td><td rowspan="1" colspan="1">Anhidrosis</td></tr></tbody>
###xml 448 3814 448 3814 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">AA change</th><th rowspan="1" colspan="1">Origin</th><th rowspan="1" colspan="1">Diagnosis</th><th rowspan="1" colspan="1">Inheritance</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">SAO</th><th rowspan="1" colspan="1">ALE</th><th rowspan="1" colspan="1">Sensory loss</th><th rowspan="1" colspan="1">Skin changes</th><th rowspan="1" colspan="1">Amputations</th><th rowspan="1" colspan="1">Bone complications</th><th rowspan="1" colspan="1">Autonomic symptoms</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ala352Val</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN1</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">16y</td><td rowspan="1" colspan="1">Sensory abnormalities</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Severe LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td></tr><tr><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ser331Phe</td><td rowspan="1" colspan="1">France (Gypsy)</td><td rowspan="1" colspan="1">HSAN/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Severe loss of superficial touch distal LL, insensitivity to pain</td><td rowspan="1" colspan="1">eschar and ulceration foot</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Gastro- oesophageal reflux</td></tr><tr><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">37y</td><td rowspan="1" colspan="1">Osteomyelitis toes</td><td rowspan="1" colspan="1">54y</td><td rowspan="1" colspan="1">Diminished L&gt;R</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the toes</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">UK</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">28y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">64y</td><td rowspan="1" colspan="1">Severe in distal LL, position sense conserved, UL less pronounced</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (all toes R foot)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Weakness in LL</td><td rowspan="1" colspan="1">75y</td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">13y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Ulcerations and foot callus</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">49y</td><td rowspan="1" colspan="1">Severe in LL (toes and feet)</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Steppage gait</td><td rowspan="1" colspan="1">34y</td><td rowspan="1" colspan="1">No clinical sensory loss</td><td rowspan="1" colspan="1">Multiple ulceration toes</td><td rowspan="1" colspan="1">+ (lower leg L, several toes R)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">USA</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">ad</td><td rowspan="1" colspan="1">Gait disturbances</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Ile355AsnfsX7</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;2y</td><td rowspan="1" colspan="1">Ulcerations hand and feet, poor healing</td><td rowspan="1" colspan="1">5y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations toes and fingers</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Spontaneous fractures LL + Charcot atropathy</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Gln184X</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">inf</td><td rowspan="1" colspan="1">Clumsiness hands, osteomyelitis in the foot</td><td rowspan="1" colspan="1">50y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations</td><td rowspan="1" colspan="1">+ (fingers and toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the foot</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Pro85ProfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;1y</td><td rowspan="1" colspan="1">Difficulties in hand manipulation</td><td rowspan="1" colspan="1">33y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations in hands and feet</td><td rowspan="1" colspan="1">+ (progressive spontaneous amputations hands, and LL to knees)</td><td rowspan="1" colspan="1">Painless pathologic fractures LL</td><td rowspan="1" colspan="1">Unk</td></tr><tr><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gly181GlyfsX16</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Delayed motor milestones?</td><td rowspan="1" colspan="1">12y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Thickening and ulcerations LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis</td></tr><tr><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.359+ 5G&gt;T aberrant splicing</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;8m</td><td rowspan="1" colspan="1">Fever of unknown cause</td><td rowspan="1" colspan="1">14y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg761Trp</td><td rowspan="1" colspan="1">The Netherlands</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Anhidrosis, hyperthermia, hypotonia</td><td rowspan="1" colspan="1">3y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Painless fracture right calcaneus</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.2046+ 3 A&gt;C aberrant splicing</td><td rowspan="1" colspan="1">Spain</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Skin ulcerations</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Insensitivity to pain and temperature</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg565Gln</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR (cons)</td><td rowspan="1" colspan="1">4 yrs</td><td rowspan="1" colspan="1">Painless tibial fracture, poor healing</td><td rowspan="1" colspan="1">35y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Multiple factures (pelvic bone, upper and lower limbs and foot bones), osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis</td></tr><tr><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gln626GlnfsX7</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC (cons)</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Hypotonia, recurrent episodes of fever</td><td rowspan="1" colspan="1">2y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Keratodermatitis, xerodermia, selfmutilation of fingers and tongue, necrotizing fasciitis of right hand</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fevers</td></tr><tr><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.354_359+3 delTCGCCTGAA aberront splicing</td><td rowspan="1" colspan="1">Turkey</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Fever, recurrent infections</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations, nail dystrophy, automutilations, neck abscess</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Avascular necrosis left talus</td><td rowspan="1" colspan="1">Anhidrosis</td></tr></tbody></table>
###xml 3814 4220 3814 4220 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="24">AA = amino acid; AAO = age at onset (years); SAO = symptoms at onset; ALE = age at last exam (y); cong = congenital; inf = infancy; ad = adulthood; IC = isolated case; AD = autosomal dominant; AR = autosomal recessive; Fam = familial; cons = consanguineous; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; unk = unknown; dist = distal; prox = proximal; R = right; L = left.; y = year; m = month.</p>
###xml 3814 4220 3814 4220 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="24">AA = amino acid; AAO = age at onset (years); SAO = symptoms at onset; ALE = age at last exam (y); cong = congenital; inf = infancy; ad = adulthood; IC = isolated case; AD = autosomal dominant; AR = autosomal recessive; Fam = familial; cons = consanguineous; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; unk = unknown; dist = distal; prox = proximal; R = right; L = left.; y = year; m = month.</p></fn>
###xml 3814 4220 3814 4220 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="24">AA = amino acid; AAO = age at onset (years); SAO = symptoms at onset; ALE = age at last exam (y); cong = congenital; inf = infancy; ad = adulthood; IC = isolated case; AD = autosomal dominant; AR = autosomal recessive; Fam = familial; cons = consanguineous; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; unk = unknown; dist = distal; prox = proximal; R = right; L = left.; y = year; m = month.</p></fn></table-wrap-foot>
###xml 386 4220 386 4220 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p textid="23">Clinical features of HSAN patients with proven mutation</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">AA change</th><th rowspan="1" colspan="1">Origin</th><th rowspan="1" colspan="1">Diagnosis</th><th rowspan="1" colspan="1">Inheritance</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">SAO</th><th rowspan="1" colspan="1">ALE</th><th rowspan="1" colspan="1">Sensory loss</th><th rowspan="1" colspan="1">Skin changes</th><th rowspan="1" colspan="1">Amputations</th><th rowspan="1" colspan="1">Bone complications</th><th rowspan="1" colspan="1">Autonomic symptoms</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ala352Val</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN1</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">16y</td><td rowspan="1" colspan="1">Sensory abnormalities</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Severe LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td><td rowspan="1" colspan="1">&#8722;</td></tr><tr><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">Ser331Phe</td><td rowspan="1" colspan="1">France (Gypsy)</td><td rowspan="1" colspan="1">HSAN/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Severe loss of superficial touch distal LL, insensitivity to pain</td><td rowspan="1" colspan="1">eschar and ulceration foot</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Gastro- oesophageal reflux</td></tr><tr><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">37y</td><td rowspan="1" colspan="1">Osteomyelitis toes</td><td rowspan="1" colspan="1">54y</td><td rowspan="1" colspan="1">Diminished L&gt;R</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the toes</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">UK</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">28y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">64y</td><td rowspan="1" colspan="1">Severe in distal LL, position sense conserved, UL less pronounced</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">+ (all toes R foot)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Weakness in LL</td><td rowspan="1" colspan="1">75y</td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">13y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">46y</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Ulcerations and foot callus</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Leu129Phe</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">49y</td><td rowspan="1" colspan="1">Severe in LL (toes and feet)</td><td rowspan="1" colspan="1">Ulcerations toes</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Osteomyelitis and -necrosis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">15y</td><td rowspan="1" colspan="1">Steppage gait</td><td rowspan="1" colspan="1">34y</td><td rowspan="1" colspan="1">No clinical sensory loss</td><td rowspan="1" colspan="1">Multiple ulceration toes</td><td rowspan="1" colspan="1">+ (lower leg L, several toes R)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">Val162Met</td><td rowspan="1" colspan="1">USA</td><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">ad</td><td rowspan="1" colspan="1">Gait disturbances</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Ulcerations feet</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Ile355AsnfsX7</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;2y</td><td rowspan="1" colspan="1">Ulcerations hand and feet, poor healing</td><td rowspan="1" colspan="1">5y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations toes and fingers</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Spontaneous fractures LL + Charcot atropathy</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Gln184X</td><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">inf</td><td rowspan="1" colspan="1">Clumsiness hands, osteomyelitis in the foot</td><td rowspan="1" colspan="1">50y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations</td><td rowspan="1" colspan="1">+ (fingers and toes)</td><td rowspan="1" colspan="1">Osteomyelitis in the foot</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic></td><td rowspan="1" colspan="1">Pro85ProfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">HSAN2</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;1y</td><td rowspan="1" colspan="1">Difficulties in hand manipulation</td><td rowspan="1" colspan="1">33y</td><td rowspan="1" colspan="1">Distally severely reduced for all modalities, LL&gt;UL</td><td rowspan="1" colspan="1">Ulcerations in hands and feet</td><td rowspan="1" colspan="1">+ (progressive spontaneous amputations hands, and LL to knees)</td><td rowspan="1" colspan="1">Painless pathologic fractures LL</td><td rowspan="1" colspan="1">Unk</td></tr><tr><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gly181GlyfsX16</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Delayed motor milestones?</td><td rowspan="1" colspan="1">12y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Thickening and ulcerations LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis</td></tr><tr><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.359+ 5G&gt;T aberrant splicing</td><td rowspan="1" colspan="1">Belgium</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">&lt;8m</td><td rowspan="1" colspan="1">Fever of unknown cause</td><td rowspan="1" colspan="1">14y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg761Trp</td><td rowspan="1" colspan="1">The Netherlands</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Anhidrosis, hyperthermia, hypotonia</td><td rowspan="1" colspan="1">3y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Painless fracture right calcaneus</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.2046+ 3 A&gt;C aberrant splicing</td><td rowspan="1" colspan="1">Spain</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Skin ulcerations</td><td rowspan="1" colspan="1">20y</td><td rowspan="1" colspan="1">Insensitivity to pain and temperature</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations</td><td rowspan="1" colspan="1">+ (toes)</td><td rowspan="1" colspan="1">Osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis, fever episodes</td></tr><tr><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Arg565Gln</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">AR (cons)</td><td rowspan="1" colspan="1">4 yrs</td><td rowspan="1" colspan="1">Painless tibial fracture, poor healing</td><td rowspan="1" colspan="1">35y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Multiple factures (pelvic bone, upper and lower limbs and foot bones), osteomyelitis</td><td rowspan="1" colspan="1">Anhidrosis</td></tr><tr><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">Gln626GlnfsX7</td><td rowspan="1" colspan="1">The Netherlands (Moroccan origin)</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC (cons)</td><td rowspan="1" colspan="1">cong</td><td rowspan="1" colspan="1">Hypotonia, recurrent episodes of fever</td><td rowspan="1" colspan="1">2y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Keratodermatitis, xerodermia, selfmutilation of fingers and tongue, necrotizing fasciitis of right hand</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Anhidrosis, fevers</td></tr><tr><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">c.354_359+3 delTCGCCTGAA aberront splicing</td><td rowspan="1" colspan="1">Turkey</td><td rowspan="1" colspan="1">HSAN4/CIPA</td><td rowspan="1" colspan="1">IC</td><td rowspan="1" colspan="1">5m</td><td rowspan="1" colspan="1">Fever, recurrent infections</td><td rowspan="1" colspan="1">7y</td><td rowspan="1" colspan="1">Insensitivity to pain</td><td rowspan="1" colspan="1">Hyperkeratosis, ulcerations, nail dystrophy, automutilations, neck abscess</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Avascular necrosis left talus</td><td rowspan="1" colspan="1">Anhidrosis</td></tr></tbody></table><table-wrap-foot><fn><p textid="24">AA = amino acid; AAO = age at onset (years); SAO = symptoms at onset; ALE = age at last exam (y); cong = congenital; inf = infancy; ad = adulthood; IC = isolated case; AD = autosomal dominant; AR = autosomal recessive; Fam = familial; cons = consanguineous; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; unk = unknown; dist = distal; prox = proximal; R = right; L = left.; y = year; m = month.</p></fn></table-wrap-foot></table-wrap>
###xml 4220 4227 4220 4227 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</label>
###xml 4227 4282 4227 4282 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="25">Clinical features of HSAN patients with proven mutation</p>
###xml 4227 4282 4227 4282 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="25">Clinical features of HSAN patients with proven mutation</p></caption>
###xml 4282 4289 4282 4289 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Patient</th>
###xml 4289 4303 4289 4303 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene/AA change</th>
###xml 4303 4319 4303 4319 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Foot deformities</th>
###xml 4319 4339 4319 4339 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Walking difficulties</th>
###xml 4339 4347 4339 4347 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Weakness</th>
###xml 4347 4354 4347 4354 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Atrophy</th>
###xml 4354 4362 4354 4362 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Reflexes</th>
###xml 4362 4380 4362 4380 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mental retardation</th>
###xml 4423 4423 4423 4423 <hr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 4380 4423 4380 4423 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="2" rowspan="1">Nerve conduction studies + electromyography<hr/></th>
###xml 4423 4442 4423 4442 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Additional features</th>
###xml 4442 4451 4442 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Reference</th>
###xml 4282 4451 4282 4451 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene/AA change</th><th rowspan="1" colspan="1">Foot deformities</th><th rowspan="1" colspan="1">Walking difficulties</th><th rowspan="1" colspan="1">Weakness</th><th rowspan="1" colspan="1">Atrophy</th><th rowspan="1" colspan="1">Reflexes</th><th rowspan="1" colspan="1">Mental retardation</th><th colspan="2" rowspan="1">Nerve conduction studies + electromyography<hr/></th><th rowspan="1" colspan="1">Additional features</th><th rowspan="1" colspan="1">Reference</th></tr>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4451 4451 4451 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4458 4451 4458 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sensory</th>
###xml 4458 4463 4458 4463 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Motor</th>
###xml 4463 4463 4463 4463 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4463 4463 4463 4463 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 4451 4463 4451 4463 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Sensory</th><th rowspan="1" colspan="1">Motor</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr>
###xml 4282 4463 4282 4463 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene/AA change</th><th rowspan="1" colspan="1">Foot deformities</th><th rowspan="1" colspan="1">Walking difficulties</th><th rowspan="1" colspan="1">Weakness</th><th rowspan="1" colspan="1">Atrophy</th><th rowspan="1" colspan="1">Reflexes</th><th rowspan="1" colspan="1">Mental retardation</th><th colspan="2" rowspan="1">Nerve conduction studies + electromyography<hr/></th><th rowspan="1" colspan="1">Additional features</th><th rowspan="1" colspan="1">Reference</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Sensory</th><th rowspan="1" colspan="1">Motor</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead>
###xml 4463 4473 4463 4473 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-186.05</td>
###xml 4473 4479 4473 4479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 4473 4489 4473 4489 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>SPTLC1</italic> Ala352Val</td>
###xml 4489 4503 4489 4503 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild pes cavus</td>
###xml 4503 4511 4503 4511 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Steppage</td>
###xml 4511 4520 4511 4520 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL</td>
###xml 4520 4528 4520 4528 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Peroneal</td>
###xml 4528 4541 4528 4541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+, Ach absent</td>
###xml 4541 4542 4541 4542 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 4542 4577 4542 4577 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td>
###xml 4577 4596 4577 4596 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses LL</td>
###xml 4596 4651 4596 4651 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe hypesthesia and spontaneaous lancinating pain LL</td>
###xml 4651 4663 4651 4663 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Novel family</td>
###xml 4463 4663 4463 4663 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ala352Val</td><td rowspan="1" colspan="1">Mild pes cavus</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">+, Ach absent</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Severe hypesthesia and spontaneaous lancinating pain LL</td><td rowspan="1" colspan="1">Novel family</td></tr>
###xml 4663 4673 4663 4673 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-791.01</td>
###xml 4673 4679 4673 4679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 4673 4689 4673 4689 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>SPTLC1</italic> Ser331Phe</td>
###xml 4689 4710 4689 4710 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pes cavus/equinovarus</td>
###xml 4710 4711 4710 4711 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 4711 4721 4711 4721 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (global)</td>
###xml 4721 4748 4721 4748 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Global amyotrophy UL and LL</td>
###xml 4748 4764 4748 4751 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595;/&#8722;</td>
###xml 4764 4779 4751 4766 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+, microcephaly</td>
###xml 4779 4801 4766 4788 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses UL/LL</td>
###xml 4801 4823 4788 4810 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses UL/LL</td>
###xml 4823 4997 4810 4984 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Severe growth retardation, hypotonia, joint hyperlaxity, vocal cord paralysis, bilateral cataract, respiratory involvement with sleep apnea requiring non-invasive ventilation</td>
###xml 4997 5009 4984 4996 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Novel family</td>
###xml 4663 5009 4663 4996 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ser331Phe</td><td rowspan="1" colspan="1">Pes cavus/equinovarus</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+ (global)</td><td rowspan="1" colspan="1">Global amyotrophy UL and LL</td><td rowspan="1" colspan="1">&#8595;/&#8722;</td><td rowspan="1" colspan="1">+, microcephaly</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Severe growth retardation, hypotonia, joint hyperlaxity, vocal cord paralysis, bilateral cataract, respiratory involvement with sleep apnea requiring non-invasive ventilation</td><td rowspan="1" colspan="1">Novel family</td></tr>
###xml 5009 5018 4996 5005 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PN-626.01</td>
###xml 5018 5022 5005 5009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 5018 5032 5005 5019 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td>
###xml 5032 5033 5019 5020 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5033 5045 5020 5032 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Steppage L&gt;R</td>
###xml 5045 5067 5032 5054 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal and proximal LL</td>
###xml 5067 5070 5054 5057 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 5070 5090 5057 5064 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595; (L&lt;R)</td>
###xml 5090 5091 5064 5065 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5091 5126 5065 5100 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td>
###xml 5126 5156 5100 5130 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal UL, absent responses LL</td>
###xml 5156 5252 5130 5226 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Brown-S&#233;quard syndrome and quadriplegia due to bleeding cervical spinal angioma, IgA nephropathy</td>
###xml 5263 5268 5237 5242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 5271 5275 5245 5249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 5252 5276 5226 5250 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 5009 5276 4996 5250 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Steppage L&gt;R</td><td rowspan="1" colspan="1">Distal and proximal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595; (L&lt;R)</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Normal UL, absent responses LL</td><td rowspan="1" colspan="1">Brown-S&#233;quard syndrome and quadriplegia due to bleeding cervical spinal angioma, IgA nephropathy</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 5276 5285 5250 5259 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-90.01</td>
###xml 5285 5289 5259 5263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 5285 5299 5259 5273 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td>
###xml 5299 5323 5273 5297 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Multiple toe amputations</td>
###xml 5323 5331 5297 5305 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Steppage</td>
###xml 5331 5343 5305 5317 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal in LL</td>
###xml 5343 5351 5317 5325 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Peroneal</td>
###xml 5351 5370 5325 5331 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595; to &#8722;</td>
###xml 5370 5371 5331 5332 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5371 5406 5332 5367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td>
###xml 5406 5436 5367 5397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UL normal, absent responses LL</td>
###xml 5436 5437 5397 5398 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5448 5453 5409 5414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 5456 5460 5417 5421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 5437 5461 5398 5422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 5276 5461 5250 5422 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Multiple toe amputations</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal in LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">UL normal, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 5461 5471 5422 5432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-126.01</td>
###xml 5471 5475 5432 5436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 5471 5485 5432 5446 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td>
###xml 5485 5494 5446 5455 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pes cavus</td>
###xml 5494 5504 5455 5465 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (severe)</td>
###xml 5504 5516 5465 5477 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL&gt;UL</td>
###xml 5516 5524 5477 5485 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Peroneal</td>
###xml 5524 5538 5485 5486 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595;</td>
###xml 5538 5539 5486 5487 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5539 5574 5487 5522 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td>
###xml 5574 5609 5522 5557 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td>
###xml 5609 5610 5557 5558 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5621 5626 5569 5574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 5629 5633 5577 5581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 5610 5634 5558 5582 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 5461 5634 5422 5582 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">+ (severe)</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 5634 5644 5582 5592 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-140.01</td>
###xml 5644 5648 5592 5596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 5644 5658 5592 5606 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td>
###xml 5658 5667 5606 5615 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pes cavus</td>
###xml 5667 5685 5615 5633 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild steppage gait</td>
###xml 5685 5707 5633 5655 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal UL and LL, mild</td>
###xml 5707 5727 5655 5675 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild in UL and in LL</td>
###xml 5727 5741 5675 5676 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595;</td>
###xml 5741 5742 5676 5677 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5742 5767 5677 5702 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal UL, axonal loss LL</td>
###xml 5767 5806 5702 5741 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal- demyelinating NCVs in UL and LL</td>
###xml 5806 5807 5741 5742 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5818 5823 5753 5758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 5826 5830 5761 5765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 5807 5831 5742 5766 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 5634 5831 5582 5766 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal UL and LL, mild</td><td rowspan="1" colspan="1">Mild in UL and in LL</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Axonal- demyelinating NCVs in UL and LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 5831 5841 5766 5776 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-186.26</td>
###xml 5841 5845 5776 5780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 5841 5855 5776 5790 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td>
###xml 5855 5877 5790 5812 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Charcot foot deformity</td>
###xml 5877 5895 5812 5830 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild steppage gait</td>
###xml 5895 5910 5830 5845 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL, mild</td>
###xml 5910 5939 5845 5874 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL, small foot muscles</td>
###xml 5939 5951 5874 5875 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8593;</td>
###xml 5951 5952 5875 5876 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 5952 5977 5876 5901 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal UL, axonal loss LL</td>
###xml 5977 6002 5901 5926 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal UL, axonal loss LL</td>
###xml 6002 6003 5926 5927 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6014 6019 5938 5943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6022 6026 5946 5950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 6003 6027 5927 5951 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 5831 6027 5766 5951 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Charcot foot deformity</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal LL, mild</td><td rowspan="1" colspan="1">Distal LL, small foot muscles</td><td rowspan="1" colspan="1">&#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 6027 6037 5951 5961 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-186.28</td>
###xml 6037 6041 5961 5965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 6037 6051 5961 5975 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td>
###xml 6051 6066 5975 5990 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Toe deformities</td>
###xml 6066 6114 5990 6038 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Steppage, after amputation, wheelchair dependent</td>
###xml 6114 6126 6038 6050 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL&gt;UL</td>
###xml 6126 6144 6050 6068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Peroneal and hands</td>
###xml 6144 6161 6068 6074 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ to &#8593;</td>
###xml 6161 6162 6074 6075 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6162 6181 6075 6094 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses LL</td>
###xml 6181 6200 6094 6113 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses LL</td>
###xml 6200 6201 6113 6114 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6212 6217 6125 6130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6220 6224 6133 6137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 6201 6225 6114 6138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 6027 6225 5951 6138 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Toe deformities</td><td rowspan="1" colspan="1">Steppage, after amputation, wheelchair dependent</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal and hands</td><td rowspan="1" colspan="1">+ to &#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 6225 6235 6138 6148 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-195.01</td>
###xml 6235 6239 6148 6152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 6235 6249 6148 6162 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td>
###xml 6249 6271 6162 6184 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Pes cavus, hammer toes</td>
###xml 6271 6279 6184 6192 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Steppage</td>
###xml 6279 6288 6192 6201 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Distal LL</td>
###xml 6288 6291 6201 6204 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 6291 6305 6204 6205 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595;</td>
###xml 6305 6306 6205 6206 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6306 6317 6206 6217 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss</td>
###xml 6317 6328 6217 6228 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss</td>
###xml 6328 6329 6228 6229 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6340 6345 6240 6245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6348 6352 6248 6252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 6329 6353 6229 6253 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td>
###xml 6225 6353 6138 6253 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Pes cavus, hammer toes</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr>
###xml 6353 6363 6253 6263 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-178.01</td>
###xml 6363 6367 6263 6267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 6363 6381 6263 6281 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>HSN2</italic> Ile355AsnfsX7</td>
###xml 6381 6382 6281 6282 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6382 6383 6282 6283 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6383 6384 6283 6284 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6384 6385 6284 6285 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6385 6386 6285 6286 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6386 6387 6286 6287 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6387 6409 6287 6309 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses UL/LL</td>
###xml 6409 6415 6309 6315 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 6415 6416 6315 6316 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6422 6427 6322 6327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6430 6434 6330 6334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2006</xref>
###xml 6416 6435 6316 6335 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td>
###xml 6353 6435 6253 6335 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Ile355AsnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr>
###xml 6435 6445 6335 6345 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-260.01</td>
###xml 6445 6449 6345 6349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 6445 6457 6345 6357 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>HSN2</italic> Gln184X</td>
###xml 6457 6493 6357 6393 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Deformed due to recurrent infections</td>
###xml 6493 6521 6393 6421 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Disturbed due to amputations</td>
###xml 6521 6522 6421 6422 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6522 6523 6422 6423 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6523 6542 6423 6429 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595; to &#8722;</td>
###xml 6542 6543 6429 6430 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6543 6565 6430 6452 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses UL/LL</td>
###xml 6565 6590 6452 6477 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">UL normal, LL axonal loss</td>
###xml 6590 6591 6477 6478 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6597 6602 6484 6489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6605 6609 6492 6496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2006</xref>
###xml 6591 6610 6478 6497 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td>
###xml 6435 6610 6335 6497 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Gln184X</td><td rowspan="1" colspan="1">Deformed due to recurrent infections</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">UL normal, LL axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr>
###xml 6610 6620 6497 6507 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-451.04</td>
###xml 6620 6624 6507 6511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 6620 6655 6507 6542 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>HSN2</italic> Pro85HisfsX14 + Gln364SerfsX16</td>
###xml 6655 6656 6542 6543 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6656 6684 6543 6571 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Disturbed due to amputations</td>
###xml 6684 6685 6571 6572 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6685 6686 6572 6573 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6686 6687 6573 6574 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6687 6688 6574 6575 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6688 6710 6575 6597 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Absent responses UL/LL</td>
###xml 6710 6716 6597 6603 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 6716 6793 6603 6680 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sural nerve biopsy: complete loss of myelinated fibers, endoneuronal fibrosis</td>
###xml 6799 6804 6686 6691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6807 6811 6694 6698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2006</xref>
###xml 6793 6812 6680 6699 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td>
###xml 6610 6812 6497 6699 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Pro85HisfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Sural nerve biopsy: complete loss of myelinated fibers, endoneuronal fibrosis</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr>
###xml 6812 6822 6699 6709 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-179.01</td>
###xml 6822 6827 6709 6714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 6822 6842 6709 6729 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> Gly181GlyfsX16</td>
###xml 6842 6843 6729 6730 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6843 6844 6730 6731 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6844 6845 6731 6732 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6845 6846 6732 6733 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6846 6847 6733 6734 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 6847 6848 6734 6735 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 6848 6851 6735 6738 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 6851 6854 6738 6741 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 6854 6919 6741 6806 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Henoch-Sch&#246;nlein vasculitis, pseudotumor cerebri, tooth abscesses</td>
###xml 6931 6936 6818 6823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 6943 6944 6830 6831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 6939 6944 6826 6831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2006<italic>b</italic></xref>
###xml 6919 6945 6806 6832 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td>
###xml 6812 6945 6699 6832 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gly181GlyfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Henoch-Sch&#246;nlein vasculitis, pseudotumor cerebri, tooth abscesses</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr>
###xml 6945 6955 6832 6842 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-197.01</td>
###xml 6955 6960 6842 6847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 6955 6971 6842 6858 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> c.359+5G&gt;T</td>
###xml 6971 6974 6858 6861 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 6974 6977 6861 6864 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 6977 6978 6864 6865 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6978 6979 6865 6866 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 6979 6993 6866 6867 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595;</td>
###xml 6993 6994 6867 6868 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 6994 6997 6868 6871 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 6997 7000 6871 6874 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 7000 7073 6874 6947 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Skin biopsy: innervation of blood vessels and eccrine sweat glands absent</td>
###xml 7085 7090 6959 6964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 7097 7098 6971 6972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 7093 7098 6967 6972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2006<italic>b</italic></xref>
###xml 7073 7099 6947 6973 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td>
###xml 6945 7099 6832 6973 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.359+5G&gt;T</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Skin biopsy: innervation of blood vessels and eccrine sweat glands absent</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr>
###xml 7099 7109 6973 6983 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-366.01</td>
###xml 7109 7114 6983 6988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 7109 7124 6983 6998 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> Arg761Trp</td>
###xml 7124 7156 6998 7030 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Charcot joint on the right ankle</td>
###xml 7156 7162 7030 7036 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 7162 7163 7036 7037 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7163 7164 7037 7038 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7164 7165 7038 7039 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 7165 7168 7039 7042 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 7168 7171 7042 7045 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 7171 7174 7045 7048 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 7174 7175 7048 7049 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7187 7192 7061 7066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 7199 7200 7073 7074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 7195 7200 7069 7074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2006<italic>b</italic></xref>
###xml 7175 7201 7049 7075 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td>
###xml 7099 7201 6973 7075 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg761Trp</td><td rowspan="1" colspan="1">Charcot joint on the right ankle</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr>
###xml 7201 7211 7075 7085 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-826.01</td>
###xml 7211 7216 7085 7090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 7211 7228 7085 7102 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> c.2046+3A&gt;C</td>
###xml 7228 7266 7102 7140 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Charcot joint on both ankles and knees</td>
###xml 7266 7296 7140 7170 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Disturbed due to Charcot joint</td>
###xml 7296 7297 7170 7171 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7297 7298 7171 7172 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7298 7312 7172 7173 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595;</td>
###xml 7312 7320 7173 7181 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+ (mild)</td>
###xml 7320 7334 7181 7195 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss LL</td>
###xml 7334 7351 7195 7212 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Axonal loss UL/LL</td>
###xml 7351 7368 7212 7229 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Corneal opacities</td>
###xml 7368 7380 7229 7241 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Novel family</td>
###xml 7201 7380 7075 7241 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.2046+3A&gt;C</td><td rowspan="1" colspan="1">Charcot joint on both ankles and knees</td><td rowspan="1" colspan="1">Disturbed due to Charcot joint</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+ (mild)</td><td rowspan="1" colspan="1">Axonal loss LL</td><td rowspan="1" colspan="1">Axonal loss UL/LL</td><td rowspan="1" colspan="1">Corneal opacities</td><td rowspan="1" colspan="1">Novel family</td></tr>
###xml 7380 7390 7241 7251 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-841.01</td>
###xml 7390 7395 7251 7256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 7390 7405 7251 7266 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> Arg565Gln</td>
###xml 7405 7443 7266 7304 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Charcot deformity right ankle and knee</td>
###xml 7443 7462 7304 7323 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Walks with rollator</td>
###xml 7462 7463 7323 7324 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7463 7464 7324 7325 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7464 7483 7325 7331 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8595; to &#8722;</td>
###xml 7483 7536 7331 7384 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722; (younger affected sister has learning difficulties)</td>
###xml 7536 7539 7384 7387 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 7539 7542 7387 7390 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Unk</td>
###xml 7542 7712 7390 7560 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Sural nerve biopsy: loss of thinly myelinated fibers, partial caudacompression syndrome age 34 yrs. traumatic cataract right eye, hearing loss due to ear drum perforation</td>
###xml 7774 7779 7622 7627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 7712 7787 7560 7635 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Novel family, clinical description previously reported (Kruyt <italic>et al</italic>., 2007)</td>
###xml 7380 7787 7241 7635 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg565Gln</td><td rowspan="1" colspan="1">Charcot deformity right ankle and knee</td><td rowspan="1" colspan="1">Walks with rollator</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8722; (younger affected sister has learning difficulties)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Sural nerve biopsy: loss of thinly myelinated fibers, partial caudacompression syndrome age 34 yrs. traumatic cataract right eye, hearing loss due to ear drum perforation</td><td rowspan="1" colspan="1">Novel family, clinical description previously reported (Kruyt <italic>et al</italic>., 2007)</td></tr>
###xml 7787 7797 7635 7645 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PN-1192.03</td>
###xml 7797 7802 7645 7650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 7797 7816 7645 7664 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> Gln626GlnfsX7</td>
###xml 7816 7817 7664 7665 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7817 7818 7665 7666 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7818 7819 7666 7667 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7819 7820 7667 7668 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 7820 7821 7668 7669 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 7821 7822 7669 7670 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 7822 7828 7670 7676 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 7828 7834 7676 7682 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 7834 7940 7682 7788 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Skin biopsy: absent innervation of capillaries and sweat glands, loss of myelinated and unmyelinated axons</td>
###xml 7952 7957 7800 7805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 7964 7965 7812 7813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 7960 7965 7808 7813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2006<italic>b</italic></xref>
###xml 7940 7966 7788 7814 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td>
###xml 7787 7966 7635 7814 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gln626GlnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Skin biopsy: absent innervation of capillaries and sweat glands, loss of myelinated and unmyelinated axons</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr>
###xml 7966 7976 7814 7824 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT-886.01</td>
###xml 7976 7981 7824 7829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 7976 8007 7824 7855 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic> c.354_359+ 3 delTCGCCTGAA</td>
###xml 8007 8008 7855 7856 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 8008 8032 7856 7880 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Delayed motor milestones</td>
###xml 8032 8033 7880 7881 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 8033 8034 7881 7882 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;</td>
###xml 8034 8035 7882 7883 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 8035 8036 7883 7884 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">+</td>
###xml 8036 8042 7884 7890 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 8042 8048 7890 7896 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</td>
###xml 8048 8168 7896 8016 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Recurrent infections respiratory and gastrointestinal tract due to hypogammaglobulinemia, recurrent hip dislocation left</td>
###xml 8175 8180 8023 8028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 8168 8188 8016 8036 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Kilic <italic>et al</italic>., 2009)</td>
###xml 7966 8188 7814 8036 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.354_359+ 3 delTCGCCTGAA</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Delayed motor milestones</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Recurrent infections respiratory and gastrointestinal tract due to hypogammaglobulinemia, recurrent hip dislocation left</td><td rowspan="1" colspan="1">(Kilic <italic>et al</italic>., 2009)</td></tr>
###xml 4463 8188 4463 8036 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ala352Val</td><td rowspan="1" colspan="1">Mild pes cavus</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">+, Ach absent</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Severe hypesthesia and spontaneaous lancinating pain LL</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ser331Phe</td><td rowspan="1" colspan="1">Pes cavus/equinovarus</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+ (global)</td><td rowspan="1" colspan="1">Global amyotrophy UL and LL</td><td rowspan="1" colspan="1">&#8595;/&#8722;</td><td rowspan="1" colspan="1">+, microcephaly</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Severe growth retardation, hypotonia, joint hyperlaxity, vocal cord paralysis, bilateral cataract, respiratory involvement with sleep apnea requiring non-invasive ventilation</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Steppage L&gt;R</td><td rowspan="1" colspan="1">Distal and proximal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595; (L&lt;R)</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Normal UL, absent responses LL</td><td rowspan="1" colspan="1">Brown-S&#233;quard syndrome and quadriplegia due to bleeding cervical spinal angioma, IgA nephropathy</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Multiple toe amputations</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal in LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">UL normal, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">+ (severe)</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal UL and LL, mild</td><td rowspan="1" colspan="1">Mild in UL and in LL</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Axonal- demyelinating NCVs in UL and LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Charcot foot deformity</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal LL, mild</td><td rowspan="1" colspan="1">Distal LL, small foot muscles</td><td rowspan="1" colspan="1">&#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Toe deformities</td><td rowspan="1" colspan="1">Steppage, after amputation, wheelchair dependent</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal and hands</td><td rowspan="1" colspan="1">+ to &#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Pes cavus, hammer toes</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Ile355AsnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Gln184X</td><td rowspan="1" colspan="1">Deformed due to recurrent infections</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">UL normal, LL axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Pro85HisfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Sural nerve biopsy: complete loss of myelinated fibers, endoneuronal fibrosis</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gly181GlyfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Henoch-Sch&#246;nlein vasculitis, pseudotumor cerebri, tooth abscesses</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.359+5G&gt;T</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Skin biopsy: innervation of blood vessels and eccrine sweat glands absent</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg761Trp</td><td rowspan="1" colspan="1">Charcot joint on the right ankle</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.2046+3A&gt;C</td><td rowspan="1" colspan="1">Charcot joint on both ankles and knees</td><td rowspan="1" colspan="1">Disturbed due to Charcot joint</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+ (mild)</td><td rowspan="1" colspan="1">Axonal loss LL</td><td rowspan="1" colspan="1">Axonal loss UL/LL</td><td rowspan="1" colspan="1">Corneal opacities</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg565Gln</td><td rowspan="1" colspan="1">Charcot deformity right ankle and knee</td><td rowspan="1" colspan="1">Walks with rollator</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8722; (younger affected sister has learning difficulties)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Sural nerve biopsy: loss of thinly myelinated fibers, partial caudacompression syndrome age 34 yrs. traumatic cataract right eye, hearing loss due to ear drum perforation</td><td rowspan="1" colspan="1">Novel family, clinical description previously reported (Kruyt <italic>et al</italic>., 2007)</td></tr><tr><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gln626GlnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Skin biopsy: absent innervation of capillaries and sweat glands, loss of myelinated and unmyelinated axons</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.354_359+ 3 delTCGCCTGAA</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Delayed motor milestones</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Recurrent infections respiratory and gastrointestinal tract due to hypogammaglobulinemia, recurrent hip dislocation left</td><td rowspan="1" colspan="1">(Kilic <italic>et al</italic>., 2009)</td></tr></tbody>
###xml 4282 8188 4282 8036 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene/AA change</th><th rowspan="1" colspan="1">Foot deformities</th><th rowspan="1" colspan="1">Walking difficulties</th><th rowspan="1" colspan="1">Weakness</th><th rowspan="1" colspan="1">Atrophy</th><th rowspan="1" colspan="1">Reflexes</th><th rowspan="1" colspan="1">Mental retardation</th><th colspan="2" rowspan="1">Nerve conduction studies + electromyography<hr/></th><th rowspan="1" colspan="1">Additional features</th><th rowspan="1" colspan="1">Reference</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Sensory</th><th rowspan="1" colspan="1">Motor</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ala352Val</td><td rowspan="1" colspan="1">Mild pes cavus</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">+, Ach absent</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Severe hypesthesia and spontaneaous lancinating pain LL</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ser331Phe</td><td rowspan="1" colspan="1">Pes cavus/equinovarus</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+ (global)</td><td rowspan="1" colspan="1">Global amyotrophy UL and LL</td><td rowspan="1" colspan="1">&#8595;/&#8722;</td><td rowspan="1" colspan="1">+, microcephaly</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Severe growth retardation, hypotonia, joint hyperlaxity, vocal cord paralysis, bilateral cataract, respiratory involvement with sleep apnea requiring non-invasive ventilation</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Steppage L&gt;R</td><td rowspan="1" colspan="1">Distal and proximal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595; (L&lt;R)</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Normal UL, absent responses LL</td><td rowspan="1" colspan="1">Brown-S&#233;quard syndrome and quadriplegia due to bleeding cervical spinal angioma, IgA nephropathy</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Multiple toe amputations</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal in LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">UL normal, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">+ (severe)</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal UL and LL, mild</td><td rowspan="1" colspan="1">Mild in UL and in LL</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Axonal- demyelinating NCVs in UL and LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Charcot foot deformity</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal LL, mild</td><td rowspan="1" colspan="1">Distal LL, small foot muscles</td><td rowspan="1" colspan="1">&#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Toe deformities</td><td rowspan="1" colspan="1">Steppage, after amputation, wheelchair dependent</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal and hands</td><td rowspan="1" colspan="1">+ to &#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Pes cavus, hammer toes</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Ile355AsnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Gln184X</td><td rowspan="1" colspan="1">Deformed due to recurrent infections</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">UL normal, LL axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Pro85HisfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Sural nerve biopsy: complete loss of myelinated fibers, endoneuronal fibrosis</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gly181GlyfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Henoch-Sch&#246;nlein vasculitis, pseudotumor cerebri, tooth abscesses</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.359+5G&gt;T</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Skin biopsy: innervation of blood vessels and eccrine sweat glands absent</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg761Trp</td><td rowspan="1" colspan="1">Charcot joint on the right ankle</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.2046+3A&gt;C</td><td rowspan="1" colspan="1">Charcot joint on both ankles and knees</td><td rowspan="1" colspan="1">Disturbed due to Charcot joint</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+ (mild)</td><td rowspan="1" colspan="1">Axonal loss LL</td><td rowspan="1" colspan="1">Axonal loss UL/LL</td><td rowspan="1" colspan="1">Corneal opacities</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg565Gln</td><td rowspan="1" colspan="1">Charcot deformity right ankle and knee</td><td rowspan="1" colspan="1">Walks with rollator</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8722; (younger affected sister has learning difficulties)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Sural nerve biopsy: loss of thinly myelinated fibers, partial caudacompression syndrome age 34 yrs. traumatic cataract right eye, hearing loss due to ear drum perforation</td><td rowspan="1" colspan="1">Novel family, clinical description previously reported (Kruyt <italic>et al</italic>., 2007)</td></tr><tr><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gln626GlnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Skin biopsy: absent innervation of capillaries and sweat glands, loss of myelinated and unmyelinated axons</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.354_359+ 3 delTCGCCTGAA</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Delayed motor milestones</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Recurrent infections respiratory and gastrointestinal tract due to hypogammaglobulinemia, recurrent hip dislocation left</td><td rowspan="1" colspan="1">(Kilic <italic>et al</italic>., 2009)</td></tr></tbody></table>
###xml 8188 8376 8036 8200 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="26">AA = amino acid; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; &#8595; = decreased; &#8593; = increased; unk = unknown; R = right; L = left; Ach = Achilles tendon.</p>
###xml 8188 8376 8036 8200 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="26">AA = amino acid; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; &#8595; = decreased; &#8593; = increased; unk = unknown; R = right; L = left; Ach = Achilles tendon.</p></fn>
###xml 8188 8376 8036 8200 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="26">AA = amino acid; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; &#8595; = decreased; &#8593; = increased; unk = unknown; R = right; L = left; Ach = Achilles tendon.</p></fn></table-wrap-foot>
###xml 4220 8376 4220 8200 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p textid="25">Clinical features of HSAN patients with proven mutation</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Patient</th><th rowspan="1" colspan="1">Gene/AA change</th><th rowspan="1" colspan="1">Foot deformities</th><th rowspan="1" colspan="1">Walking difficulties</th><th rowspan="1" colspan="1">Weakness</th><th rowspan="1" colspan="1">Atrophy</th><th rowspan="1" colspan="1">Reflexes</th><th rowspan="1" colspan="1">Mental retardation</th><th colspan="2" rowspan="1">Nerve conduction studies + electromyography<hr/></th><th rowspan="1" colspan="1">Additional features</th><th rowspan="1" colspan="1">Reference</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Sensory</th><th rowspan="1" colspan="1">Motor</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">CMT-186.05</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ala352Val</td><td rowspan="1" colspan="1">Mild pes cavus</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">+, Ach absent</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Severe hypesthesia and spontaneaous lancinating pain LL</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">CMT-791.01</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic> Ser331Phe</td><td rowspan="1" colspan="1">Pes cavus/equinovarus</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+ (global)</td><td rowspan="1" colspan="1">Global amyotrophy UL and LL</td><td rowspan="1" colspan="1">&#8595;/&#8722;</td><td rowspan="1" colspan="1">+, microcephaly</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Severe growth retardation, hypotonia, joint hyperlaxity, vocal cord paralysis, bilateral cataract, respiratory involvement with sleep apnea requiring non-invasive ventilation</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">PN-626.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Steppage L&gt;R</td><td rowspan="1" colspan="1">Distal and proximal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595; (L&lt;R)</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Normal UL, absent responses LL</td><td rowspan="1" colspan="1">Brown-S&#233;quard syndrome and quadriplegia due to bleeding cervical spinal angioma, IgA nephropathy</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-90.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Multiple toe amputations</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal in LL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">UL normal, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-126.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">+ (severe)</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">Axonal loss UL, absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-140.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Pes cavus</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal UL and LL, mild</td><td rowspan="1" colspan="1">Mild in UL and in LL</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Axonal- demyelinating NCVs in UL and LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-186.26</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Leu129Phe</td><td rowspan="1" colspan="1">Charcot foot deformity</td><td rowspan="1" colspan="1">Mild steppage gait</td><td rowspan="1" colspan="1">Distal LL, mild</td><td rowspan="1" colspan="1">Distal LL, small foot muscles</td><td rowspan="1" colspan="1">&#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">Normal UL, axonal loss LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-186.28</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Toe deformities</td><td rowspan="1" colspan="1">Steppage, after amputation, wheelchair dependent</td><td rowspan="1" colspan="1">Distal LL&gt;UL</td><td rowspan="1" colspan="1">Peroneal and hands</td><td rowspan="1" colspan="1">+ to &#8593;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">Absent responses LL</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-195.01</td><td rowspan="1" colspan="1"><italic>RAB7</italic> Val162Met</td><td rowspan="1" colspan="1">Pes cavus, hammer toes</td><td rowspan="1" colspan="1">Steppage</td><td rowspan="1" colspan="1">Distal LL</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">Axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-178.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Ile355AsnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-260.01</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Gln184X</td><td rowspan="1" colspan="1">Deformed due to recurrent infections</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">UL normal, LL axonal loss</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-451.04</td><td rowspan="1" colspan="1"><italic>HSN2</italic> Pro85HisfsX14 + Gln364SerfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Disturbed due to amputations</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Absent responses UL/LL</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Sural nerve biopsy: complete loss of myelinated fibers, endoneuronal fibrosis</td><td rowspan="1" colspan="1">(Coen <italic>et al</italic>., <xref ref-type="bibr" rid="B8">2006</xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-179.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gly181GlyfsX16</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Henoch-Sch&#246;nlein vasculitis, pseudotumor cerebri, tooth abscesses</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-197.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.359+5G&gt;T</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Skin biopsy: innervation of blood vessels and eccrine sweat glands absent</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-366.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg761Trp</td><td rowspan="1" colspan="1">Charcot joint on the right ankle</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-826.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.2046+3A&gt;C</td><td rowspan="1" colspan="1">Charcot joint on both ankles and knees</td><td rowspan="1" colspan="1">Disturbed due to Charcot joint</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595;</td><td rowspan="1" colspan="1">+ (mild)</td><td rowspan="1" colspan="1">Axonal loss LL</td><td rowspan="1" colspan="1">Axonal loss UL/LL</td><td rowspan="1" colspan="1">Corneal opacities</td><td rowspan="1" colspan="1">Novel family</td></tr><tr><td rowspan="1" colspan="1">CMT-841.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Arg565Gln</td><td rowspan="1" colspan="1">Charcot deformity right ankle and knee</td><td rowspan="1" colspan="1">Walks with rollator</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8595; to &#8722;</td><td rowspan="1" colspan="1">&#8722; (younger affected sister has learning difficulties)</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Unk</td><td rowspan="1" colspan="1">Sural nerve biopsy: loss of thinly myelinated fibers, partial caudacompression syndrome age 34 yrs. traumatic cataract right eye, hearing loss due to ear drum perforation</td><td rowspan="1" colspan="1">Novel family, clinical description previously reported (Kruyt <italic>et al</italic>., 2007)</td></tr><tr><td rowspan="1" colspan="1">PN-1192.03</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> Gln626GlnfsX7</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Skin biopsy: absent innervation of capillaries and sweat glands, loss of myelinated and unmyelinated axons</td><td rowspan="1" colspan="1">(Verpoorten <italic>et al</italic>., <xref ref-type="bibr" rid="B42">2006<italic>b</italic></xref>)</td></tr><tr><td rowspan="1" colspan="1">CMT-886.01</td><td rowspan="1" colspan="1"><italic>NTRK1</italic> c.354_359+ 3 delTCGCCTGAA</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">Delayed motor milestones</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">Recurrent infections respiratory and gastrointestinal tract due to hypogammaglobulinemia, recurrent hip dislocation left</td><td rowspan="1" colspan="1">(Kilic <italic>et al</italic>., 2009)</td></tr></tbody></table><table-wrap-foot><fn><p textid="26">AA = amino acid; LL = lower limb; UL = upper limb; + = present; &#8722; = absent; &#8595; = decreased; &#8593; = increased; unk = unknown; R = right; L = left; Ach = Achilles tendon.</p></fn></table-wrap-foot></table-wrap>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 4253 4261 <span type="species:ncbi:9606">patients</span>
In 19 index patients, out of a cohort of 100, pathogenic mutations were found in four HSAN disease associated genes: SPTLC1, RAB7, NTRK1 and WNK1/HSN2. These mutations were absent from 600 European control chromosomes. No pathogenic variations could be detected in NGFB, CCT5 and NGFR. Clinical and electrophysiological data on these 19 index patients are summarized in Tables 1 and 2. Table 1Clinical features of HSAN patients with proven mutationPatientGeneAA changeOriginDiagnosisInheritanceAAOSAOALESensory lossSkin changesAmputationsBone complicationsAutonomic symptomsCMT-186.05SPTLC1Ala352ValAustriaHSAN1IC16ySensory abnormalities46ySevere LL----CMT-791.01SPTLC1Ser331PheFrance (Gypsy)HSAN/CIPAICcongInsensitivity to pain7ySevere loss of superficial touch distal LL, insensitivity to paineschar and ulceration foot--Gastro- oesophageal refluxPN-626.01RAB7Val162MetBelgiumCMT2BAD37yOsteomyelitis toes54yDiminished L>RUlcerations toes+ (toes)Osteomyelitis in the toes-CMT-90.01RAB7Val162MetUKCMT2BAD28yUlcerations toes64ySevere in distal LL, position sense conserved, UL less pronouncedUlcerations toes+ (all toes R foot)Unk-CMT-126.01RAB7Leu129PheAustriaCMT2BAD15yWeakness in LL75ySevereUlcerations feet-Osteomyelitis and -necrosis-CMT-140.01RAB7Leu129PheAustriaCMT2BAD13yUlcerations toes46yModerateUlcerations and foot callus+ (toes)Osteomyelitis and -necrosis-CMT-186.26RAB7Leu129PheAustriaCMT2BAD20yUlcerations toes49ySevere in LL (toes and feet)Ulcerations toes-Osteomyelitis and -necrosis-CMT-186.28RAB7Val162MetAustriaCMT2BAD15ySteppage gait34yNo clinical sensory lossMultiple ulceration toes+ (lower leg L, several toes R)Osteomyelitis-CMT-195.01RAB7Val162MetUSACMT2BADadGait disturbancesUnkDistal LLUlcerations feetUnkUnk-CMT-178.01HSN2Ile355AsnfsX7BelgiumHSAN2IC<2yUlcerations hand and feet, poor healing5yDistally severely reduced for all modalities, LL>ULUlcerations toes and fingers-Spontaneous fractures LL + Charcot atropathy-CMT-260.01HSN2Gln184XAustriaHSAN2ICinfClumsiness hands, osteomyelitis in the foot50yDistally severely reduced for all modalities, LL>ULUlcerations+ (fingers and toes)Osteomyelitis in the foot-CMT-451.04HSN2Pro85ProfsX14 + Gln364SerfsX16ItalyHSAN2IC<1yDifficulties in hand manipulation33yDistally severely reduced for all modalities, LL>ULUlcerations in hands and feet+ (progressive spontaneous amputations hands, and LL to knees)Painless pathologic fractures LLUnkCMT-179.01NTRK1Gly181GlyfsX16BelgiumHSAN4/CIPAICcongDelayed motor milestones?12yInsensitivity to painThickening and ulcerations LL--AnhidrosisCMT-197.01NTRK1c.359+ 5G>T aberrant splicingBelgiumHSAN4/CIPAIC<8mFever of unknown cause14yInsensitivity to painUnk--Anhidrosis, fever episodesCMT-366.01NTRK1Arg761TrpThe NetherlandsHSAN4/CIPAICcongAnhidrosis, hyperthermia, hypotonia3yInsensitivity to painUnk-Painless fracture right calcaneusAnhidrosis, fever episodesCMT-826.01NTRK1c.2046+ 3 A>C aberrant splicingSpainHSAN4/CIPAAR5mSkin ulcerations20yInsensitivity to pain and temperatureHyperkeratosis, ulcerations+ (toes)OsteomyelitisAnhidrosis, fever episodesCMT-841.01NTRK1Arg565GlnThe Netherlands (Moroccan origin)HSAN4/CIPAAR (cons)4 yrsPainless tibial fracture, poor healing35yInsensitivity to pain--Multiple factures (pelvic bone, upper and lower limbs and foot bones), osteomyelitisAnhidrosisPN-1192.03NTRK1Gln626GlnfsX7The Netherlands (Moroccan origin)HSAN4/CIPAIC (cons)congHypotonia, recurrent episodes of fever2yInsensitivity to painKeratodermatitis, xerodermia, selfmutilation of fingers and tongue, necrotizing fasciitis of right hand--Anhidrosis, feversCMT-886.01NTRK1c.354_359+3 delTCGCCTGAA aberront splicingTurkeyHSAN4/CIPAIC5mFever, recurrent infections7yInsensitivity to painHyperkeratosis, ulcerations, nail dystrophy, automutilations, neck abscess-Avascular necrosis left talusAnhidrosisAA = amino acid; AAO = age at onset (years); SAO = symptoms at onset; ALE = age at last exam (y); cong = congenital; inf = infancy; ad = adulthood; IC = isolated case; AD = autosomal dominant; AR = autosomal recessive; Fam = familial; cons = consanguineous; LL = lower limb; UL = upper limb; + = present; - = absent; unk = unknown; dist = distal; prox = proximal; R = right; L = left.; y = year; m = month.Table 2Clinical features of HSAN patients with proven mutationPatientGene/AA changeFoot deformitiesWalking difficultiesWeaknessAtrophyReflexesMental retardationNerve conduction studies + electromyographyAdditional featuresReferenceSensoryMotorCMT-186.05SPTLC1 Ala352ValMild pes cavusSteppageDistal LLPeroneal+, Ach absent-Axonal loss UL, absent responses LLAbsent responses LLSevere hypesthesia and spontaneaous lancinating pain LLNovel familyCMT-791.01SPTLC1 Ser331PhePes cavus/equinovarus++ (global)Global amyotrophy UL and LLdownward arrow/-+, microcephalyAbsent responses UL/LLAbsent responses UL/LLSevere growth retardation, hypotonia, joint hyperlaxity, vocal cord paralysis, bilateral cataract, respiratory involvement with sleep apnea requiring non-invasive ventilationNovel familyPN-626.01RAB7 Val162Met-Steppage L>RDistal and proximal LLUnkdownward arrow (L<R)-Axonal loss UL, absent responses LLNormal UL, absent responses LLBrown-Sequard syndrome and quadriplegia due to bleeding cervical spinal angioma, IgA nephropathy(Verhoeven et al., 2003)CMT-90.01RAB7 Val162MetMultiple toe amputationsSteppageDistal in LLPeronealdownward arrow to --Axonal loss UL, absent responses LLUL normal, absent responses LL-(Verhoeven et al., 2003)CMT-126.01RAB7 Leu129PhePes cavus+ (severe)Distal LL>ULPeronealdownward arrow-Axonal loss UL, absent responses LLAxonal loss UL, absent responses LL-(Verhoeven et al., 2003)CMT-140.01RAB7 Leu129PhePes cavusMild steppage gaitDistal UL and LL, mildMild in UL and in LLdownward arrow-Normal UL, axonal loss LLAxonal- demyelinating NCVs in UL and LL-(Verhoeven et al., 2003)CMT-186.26RAB7 Leu129PheCharcot foot deformityMild steppage gaitDistal LL, mildDistal LL, small foot musclesupward arrow-Normal UL, axonal loss LLNormal UL, axonal loss LL-(Verhoeven et al., 2003)CMT-186.28RAB7 Val162MetToe deformitiesSteppage, after amputation, wheelchair dependentDistal LL>ULPeroneal and hands+ to upward arrow-Absent responses LLAbsent responses LL-(Verhoeven et al., 2003)CMT-195.01RAB7 Val162MetPes cavus, hammer toesSteppageDistal LLUnkdownward arrow-Axonal lossAxonal loss-(Verhoeven et al., 2003)CMT-178.01HSN2 Ile355AsnfsX7------Absent responses UL/LLNormal-(Coen et al., 2006)CMT-260.01HSN2 Gln184XDeformed due to recurrent infectionsDisturbed due to amputations--downward arrow to --Absent responses UL/LLUL normal, LL axonal loss-(Coen et al., 2006)CMT-451.04HSN2 Pro85HisfsX14 + Gln364SerfsX16-Disturbed due to amputations----Absent responses UL/LLNormalSural nerve biopsy: complete loss of myelinated fibers, endoneuronal fibrosis(Coen et al., 2006)CMT-179.01NTRK1 Gly181GlyfsX16----++UnkUnkHenoch-Schonlein vasculitis, pseudotumor cerebri, tooth abscesses(Verpoorten et al., 2006b)CMT-197.01NTRK1 c.359+5G>TUnkUnk--downward arrow+UnkUnkSkin biopsy: innervation of blood vessels and eccrine sweat glands absent(Verpoorten et al., 2006b)CMT-366.01NTRK1 Arg761TrpCharcot joint on the right ankleNormal--+UnkUnkUnk-(Verpoorten et al., 2006b)CMT-826.01NTRK1 c.2046+3A>CCharcot joint on both ankles and kneesDisturbed due to Charcot joint--downward arrow+ (mild)Axonal loss LLAxonal loss UL/LLCorneal opacitiesNovel familyCMT-841.01NTRK1 Arg565GlnCharcot deformity right ankle and kneeWalks with rollator--downward arrow to -- (younger affected sister has learning difficulties)UnkUnkSural nerve biopsy: loss of thinly myelinated fibers, partial caudacompression syndrome age 34 yrs. traumatic cataract right eye, hearing loss due to ear drum perforationNovel family, clinical description previously reported (Kruyt et al., 2007)PN-1192.03NTRK1 Gln626GlnfsX7----++NormalNormalSkin biopsy: absent innervation of capillaries and sweat glands, loss of myelinated and unmyelinated axons(Verpoorten et al., 2006b)CMT-886.01NTRK1 c.354_359+ 3 delTCGCCTGAA-Delayed motor milestones--++NormalNormalRecurrent infections respiratory and gastrointestinal tract due to hypogammaglobulinemia, recurrent hip dislocation left(Kilic et al., 2009)AA = amino acid; LL = lower limb; UL = upper limb; + = present; - = absent; downward arrow = decreased; upward arrow = increased; unk = unknown; R = right; L = left; Ach = Achilles tendon.
###end p 22
###begin p 23
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Clinical features of HSAN patients with proven mutation
###end p 23
###begin p 24
AA = amino acid; AAO = age at onset (years); SAO = symptoms at onset; ALE = age at last exam (y); cong = congenital; inf = infancy; ad = adulthood; IC = isolated case; AD = autosomal dominant; AR = autosomal recessive; Fam = familial; cons = consanguineous; LL = lower limb; UL = upper limb; + = present; - = absent; unk = unknown; dist = distal; prox = proximal; R = right; L = left.; y = year; m = month.
###end p 24
###begin p 25
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Clinical features of HSAN patients with proven mutation
###end p 25
###begin p 26
AA = amino acid; LL = lower limb; UL = upper limb; + = present; - = absent; downward arrow = decreased; upward arrow = increased; unk = unknown; R = right; L = left; Ach = Achilles tendon.
###end p 26
###begin title 27
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
Mutations in SPTLC1
###end title 27
###begin p 28
###xml 135 141 135 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 511 517 511 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 659 664 659 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">2004</xref>
###xml 1050 1052 1050 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 1200 1205 1200 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1208 1212 1208 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2009</xref>
###xml 1215 1223 1215 1223 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</label>
###xml 1296 1297 1296 1297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1302 1303 1302 1303 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1379 1384 1379 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 1386 1387 1386 1387 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1392 1393 1392 1393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1500 1507 1500 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1509 1510 1509 1510 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2340 2341 2340 2341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1223 2519 1223 2519 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="29">Segregation of p.Ser331Phe and p.Ala352Val missense mutations in SPTLC1 (<bold>A</bold> and <bold>B</bold>) and segregation and cDNA analysis of the p.Arg565Gln missense mutation in <italic>NTRK1</italic> (<bold>C</bold> and <bold>D</bold>). Segregation analysis of the p.Ser331Phe missense mutation in SPTLC1 reveals that this mutation occurred <italic>de novo</italic> (<bold>A</bold>). Panel B shows the sequence trace file of the p.Ala352Val missense mutation found in SPTLC1 in an isolated Patient CMT-186.05. Segregation of the p.Arg565Gln mutation in NTRK1 is shown in panel C. Two CIPA patients in family CMT-841 (CMT-841.01 and CMT-841.02) had a homozygous Arg565Gln mutation in NTRK1. The healthy siblings of these patients had either the wild-type allele (CMT-841.03 and CMT-841.07) or carried the Arg565Gln mutation in the heterozygous state (CMT-841.04, CMT-841.05 and CMT-841.06). The parents of the patients were first cousins. The mutated nucleotide (c.1697G &gt; A) was the last nucleotide of exon 14, which could affect proper splicing of this exon. cDNA analysis of CMT-841.01 showed the absence of the expected band (528 bp), which was present in the control and confirmed by direct DNA sequencing (<bold>D</bold>). We could not determine the sequence of the three lower bands present in the patient. square = male, circle = female, black filled symbol = affected, empty symbol = unaffected.</p>
###xml 1223 2519 1223 2519 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="29">Segregation of p.Ser331Phe and p.Ala352Val missense mutations in SPTLC1 (<bold>A</bold> and <bold>B</bold>) and segregation and cDNA analysis of the p.Arg565Gln missense mutation in <italic>NTRK1</italic> (<bold>C</bold> and <bold>D</bold>). Segregation analysis of the p.Ser331Phe missense mutation in SPTLC1 reveals that this mutation occurred <italic>de novo</italic> (<bold>A</bold>). Panel B shows the sequence trace file of the p.Ala352Val missense mutation found in SPTLC1 in an isolated Patient CMT-186.05. Segregation of the p.Arg565Gln mutation in NTRK1 is shown in panel C. Two CIPA patients in family CMT-841 (CMT-841.01 and CMT-841.02) had a homozygous Arg565Gln mutation in NTRK1. The healthy siblings of these patients had either the wild-type allele (CMT-841.03 and CMT-841.07) or carried the Arg565Gln mutation in the heterozygous state (CMT-841.04, CMT-841.05 and CMT-841.06). The parents of the patients were first cousins. The mutated nucleotide (c.1697G &gt; A) was the last nucleotide of exon 14, which could affect proper splicing of this exon. cDNA analysis of CMT-841.01 showed the absence of the expected band (528 bp), which was present in the control and confirmed by direct DNA sequencing (<bold>D</bold>). We could not determine the sequence of the three lower bands present in the patient. square = male, circle = female, black filled symbol = affected, empty symbol = unaffected.</p></caption>
###xml 2519 2519 2519 2519 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp198f1"/>
###xml 1215 2519 1215 2519 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1</label><caption><p textid="29">Segregation of p.Ser331Phe and p.Ala352Val missense mutations in SPTLC1 (<bold>A</bold> and <bold>B</bold>) and segregation and cDNA analysis of the p.Arg565Gln missense mutation in <italic>NTRK1</italic> (<bold>C</bold> and <bold>D</bold>). Segregation analysis of the p.Ser331Phe missense mutation in SPTLC1 reveals that this mutation occurred <italic>de novo</italic> (<bold>A</bold>). Panel B shows the sequence trace file of the p.Ala352Val missense mutation found in SPTLC1 in an isolated Patient CMT-186.05. Segregation of the p.Arg565Gln mutation in NTRK1 is shown in panel C. Two CIPA patients in family CMT-841 (CMT-841.01 and CMT-841.02) had a homozygous Arg565Gln mutation in NTRK1. The healthy siblings of these patients had either the wild-type allele (CMT-841.03 and CMT-841.07) or carried the Arg565Gln mutation in the heterozygous state (CMT-841.04, CMT-841.05 and CMT-841.06). The parents of the patients were first cousins. The mutated nucleotide (c.1697G &gt; A) was the last nucleotide of exon 14, which could affect proper splicing of this exon. cDNA analysis of CMT-841.01 showed the absence of the expected band (528 bp), which was present in the control and confirmed by direct DNA sequencing (<bold>D</bold>). We could not determine the sequence of the three lower bands present in the patient. square = male, circle = female, black filled symbol = affected, empty symbol = unaffected.</p></caption><graphic xlink:href="awp198f1"/></fig>
###xml 3 10 <span type="species:ncbi:9606">Patient</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 278 285 <span type="species:ncbi:9606">patient</span>
###xml 431 438 <span type="species:ncbi:9606">Patient</span>
###xml 598 605 <span type="species:ncbi:9606">Patient</span>
###xml 706 713 <span type="species:ncbi:9606">Patient</span>
###xml 768 775 <span type="species:ncbi:9606">patient</span>
###xml 1619 1626 <span type="species:ncbi:9606">Patient</span>
###xml 1718 1726 <span type="species:ncbi:9606">patients</span>
###xml 1849 1857 <span type="species:ncbi:9606">patients</span>
###xml 2038 2046 <span type="species:ncbi:9606">patients</span>
###xml 2420 2427 <span type="species:ncbi:9606">patient</span>
In Patient CMT-791.01, we detected a heterozygous missense mutation (c.992C>T; p.Ser331Phe), which was absent in both healthy parents (Fig. 1A). Paternity was confirmed in this family, pointing to a de novo mutation. In contrast to previously reported HSAN type I patients, the patient displayed a severe phenotype characterized by congenital onset with severe growth and mental retardation, hypotonia and vocal cord paralysis. In Patient CMT-186.05 a missense mutation (c.1055C>T; p.Ala352Val) was identified (Fig. 1B). A third heterozygous missense mutation (c.1160G>C; p.Gly387Ala) was found in Patient CMT-155.01 and her twin sister CMT-155.02 (Verhoeven et al., 2004). This mutation was also found in Patient CMT-820.01. However, the healthy mother of this index patient has the same variant in the homozygous state. This finding suggests that the Gly387Ala variation is not pathogenic, but a rare polymorphism. This has recently been confirmed by the analysis of serine palmitoyl transferase (SPT) activity by measuring the incorporation of [U-13C]-L-serine in protein extracts from stably transfected HEK293 cells and complementation testing using an SPTLC1-deficient CHO cell line (Hornemann et al., 2009). Figure 1Segregation of p.Ser331Phe and p.Ala352Val missense mutations in SPTLC1 (A and B) and segregation and cDNA analysis of the p.Arg565Gln missense mutation in NTRK1 (C and D). Segregation analysis of the p.Ser331Phe missense mutation in SPTLC1 reveals that this mutation occurred de novo (A). Panel B shows the sequence trace file of the p.Ala352Val missense mutation found in SPTLC1 in an isolated Patient CMT-186.05. Segregation of the p.Arg565Gln mutation in NTRK1 is shown in panel C. Two CIPA patients in family CMT-841 (CMT-841.01 and CMT-841.02) had a homozygous Arg565Gln mutation in NTRK1. The healthy siblings of these patients had either the wild-type allele (CMT-841.03 and CMT-841.07) or carried the Arg565Gln mutation in the heterozygous state (CMT-841.04, CMT-841.05 and CMT-841.06). The parents of the patients were first cousins. The mutated nucleotide (c.1697G > A) was the last nucleotide of exon 14, which could affect proper splicing of this exon. cDNA analysis of CMT-841.01 showed the absence of the expected band (528 bp), which was present in the control and confirmed by direct DNA sequencing (D). We could not determine the sequence of the three lower bands present in the patient. square = male, circle = female, black filled symbol = affected, empty symbol = unaffected.
###end p 28
###begin p 29
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 79 80 79 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 169 170 169 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 286 287 286 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1117 1118 1117 1118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 396 403 <span type="species:ncbi:9606">Patient</span>
###xml 495 503 <span type="species:ncbi:9606">patients</span>
###xml 626 634 <span type="species:ncbi:9606">patients</span>
###xml 815 823 <span type="species:ncbi:9606">patients</span>
###xml 1197 1204 <span type="species:ncbi:9606">patient</span>
Segregation of p.Ser331Phe and p.Ala352Val missense mutations in SPTLC1 (A and B) and segregation and cDNA analysis of the p.Arg565Gln missense mutation in NTRK1 (C and D). Segregation analysis of the p.Ser331Phe missense mutation in SPTLC1 reveals that this mutation occurred de novo (A). Panel B shows the sequence trace file of the p.Ala352Val missense mutation found in SPTLC1 in an isolated Patient CMT-186.05. Segregation of the p.Arg565Gln mutation in NTRK1 is shown in panel C. Two CIPA patients in family CMT-841 (CMT-841.01 and CMT-841.02) had a homozygous Arg565Gln mutation in NTRK1. The healthy siblings of these patients had either the wild-type allele (CMT-841.03 and CMT-841.07) or carried the Arg565Gln mutation in the heterozygous state (CMT-841.04, CMT-841.05 and CMT-841.06). The parents of the patients were first cousins. The mutated nucleotide (c.1697G > A) was the last nucleotide of exon 14, which could affect proper splicing of this exon. cDNA analysis of CMT-841.01 showed the absence of the expected band (528 bp), which was present in the control and confirmed by direct DNA sequencing (D). We could not determine the sequence of the three lower bands present in the patient. square = male, circle = female, black filled symbol = affected, empty symbol = unaffected.
###end p 29
###begin title 30
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
Mutations in RAB7
###end title 30
###begin p 31
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 797 801 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 137 145 <span type="species:ncbi:9606">Patients</span>
###xml 232 240 <span type="species:ncbi:9606">Patients</span>
###xml 477 485 <span type="species:ncbi:9606">Patients</span>
###xml 638 646 <span type="species:ncbi:9606">patients</span>
###xml 777 785 <span type="species:ncbi:9606">patients</span>
In our cohort, two different missense mutations in RAB7 have been identified in seven anamnestically unrelated index patients. The index Patients CMT-90.01 and CMT-195.01 of two multigenerational pedigrees as well as two additional Patients with a positive familial history (CMT-186.28 and PN-626.01) carried the same heterozygous transition c.484G>A resulting in a Val162Met missense mutation. The c.385C>T (p.Leu129Phe) missense mutation was detected in three Austrian index Patients: CMT-126.01, CMT-140.01 and CMT-186.26. Additional haplotype analysis revealed that the Val162Met mutation arose independently in the reported families/patients, but the Leu129Phe mutation resides on a common disease haplotype indicating a founder effect (Verhoeven et al., 2003). All index patients carrying a RAB7 mutation present with an adolescent or adult-onset HMSN II phenotype and are characterized by distal atrophy and weakness in the lower limbs with pronounced distal sensory loss complicated by ulcerations and amputations.
###end p 31
###begin title 32
###xml 13 22 13 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
Mutations in WNK1/HSN2
###end title 32
###begin p 33
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">2008</xref>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 291 298 <span type="species:ncbi:9606">patient</span>
A recent report showed that HSN2 is a nervous system-specific exon of the WNK1-gene. A compound heterozygous mutation in WNK1 and HSN2 was identified as the cause for HSAN type II (Shekarabi et al., 2008). In view of this recent finding, the entire coding region of WNK1 was screened in our patient cohort. No additional disease-related sequence variants were identified outside of the HSN2 exon.
###end p 33
###begin p 34
###xml 40 49 40 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 667 672 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2006</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 392 399 <span type="species:ncbi:9606">Patient</span>
###xml 612 620 <span type="species:ncbi:9606">Patients</span>
We identified a total of four different WNK1/HSN2 mutations in three previously reported patients: one compound heterozygous mutation consisting of a 1bp-deletion resulting in a frameshift mutation with a premature stop codon (c.254delC; p.Pro85HisfsX14) and an insertion of a thymine (c.1089_1090insT) predicted to cause a frameshift mutation with premature stop codon (p.Gln364SerfsX16) in Patient CMT-451.01. One homozygous non-sense mutation (c.550C>T; p.Gln184X) and one homozygous 2-bp deletion (c.1064_1065delTC) predicted to cause a frameshift and premature stop codon (p.Ile355AsnfsX7) were detected in Patients CMT-260.01 and CMT-178.01, respectively (Coen et al., 2006).
###end p 34
###begin title 35
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
Mutations in NTRK1
###end title 35
###begin p 36
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 154 162 154 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Tables 1</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 240 246 240 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 345 351 345 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 443 449 443 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2008</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">2009</xref>
###xml 1085 1093 1085 1093 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</label>
###xml 1180 1184 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">2000</xref>
###xml 1214 1218 1214 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">2001</xref>
###xml 1093 1273 1093 1273 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">Schematic presentation of protein structures of SPTLC1, RAB7 (Pereira-Leal and Seabra, <xref ref-type="bibr" rid="B31">2000</xref>), WNK1/HSN2 and NTRK1 (Indo, <xref ref-type="bibr" rid="B17">2001</xref>) with mutations identified in this study causing HSAN.</p>
###xml 1093 1273 1093 1273 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">Schematic presentation of protein structures of SPTLC1, RAB7 (Pereira-Leal and Seabra, <xref ref-type="bibr" rid="B31">2000</xref>), WNK1/HSN2 and NTRK1 (Indo, <xref ref-type="bibr" rid="B17">2001</xref>) with mutations identified in this study causing HSAN.</p></caption>
###xml 1273 1273 1273 1273 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp198f2"/>
###xml 1085 1273 1085 1273 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2</label><caption><p textid="37">Schematic presentation of protein structures of SPTLC1, RAB7 (Pereira-Leal and Seabra, <xref ref-type="bibr" rid="B31">2000</xref>), WNK1/HSN2 and NTRK1 (Indo, <xref ref-type="bibr" rid="B17">2001</xref>) with mutations identified in this study causing HSAN.</p></caption><graphic xlink:href="awp198f2"/></fig>
###xml 134 141 <span type="species:ncbi:9606">Patient</span>
###xml 583 590 <span type="species:ncbi:9606">Patient</span>
###xml 919 926 <span type="species:ncbi:9606">patient</span>
In our cohort, seven mutations in NTRK1 were found, of which one was a novel homozygous missense mutation (c.1697G>A; p.Arg565Gln) in Patient CMT-841.01 (Tables 1 and 2). An affected sibling CMT-841.02 carried the same homozygous mutation (Fig. 1C). This mutation targets the tyrosine kinase domain of the neurotrophin tyrosine kinase receptor (Fig. 2). The mutated nucleotide is the last base pair of exon 14, resulting in aberrant splicing (Fig. 1D). Furthermore, we identified a known 9 bp-deletion (c.354_359 + 3delTCGCCTGAA) (Tuysuz et al., 2008) in a recently reported Turkish Patient (CMT-886.01) (Kilic et al., 2009). This deletion spans the splice-donor site of exon 3. cDNA analysis revealed two splice variants; one with skipping of exon 3 and the second with skipping of exons 2 and 3. These exons contain a part of the leucine-rich motif of NTRK1, important for ligand binding and signal transduction. The patient displayed a CIPA phenotype complicated by recurrent infections secondary to hypogammaglobulinemia, a feature not previously known to be associated with CIPA. Figure 2Schematic presentation of protein structures of SPTLC1, RAB7 (Pereira-Leal and Seabra, 2000), WNK1/HSN2 and NTRK1 (Indo, 2001) with mutations identified in this study causing HSAN.
###end p 36
###begin p 37
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">2000</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">2001</xref>
Schematic presentation of protein structures of SPTLC1, RAB7 (Pereira-Leal and Seabra, 2000), WNK1/HSN2 and NTRK1 (Indo, 2001) with mutations identified in this study causing HSAN.
###end p 37
###begin p 38
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 520 525 520 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2006<italic>b</italic></xref>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">2001</xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 112 120 <span type="species:ncbi:9606">Patients</span>
###xml 223 231 <span type="species:ncbi:9606">Patients</span>
###xml 384 391 <span type="species:ncbi:9606">Patient</span>
###xml 481 488 <span type="species:ncbi:9606">Patient</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
Six additional known mutations were found in six index patients. Homozygous splice site mutations were found in Patients CMT-197.01 (c.359+5G>T) and CMT-826.01 (IVS15 +3A>C). Homozygous frameshift mutations were present in Patients PN-1192.03 (c.1877-1878insA; p.Gln626GlnfsX7) and CMT-179.01 (c.543delG; p.Gly181GlyfsX16). Finally, we identified a homozygous splice site mutation in Patient CMT-197.01 (c.359 + 5G>T) and a homozygous missense mutation (c.2281C>T; p.Arg761Trp) in Patient CMT-366.01 (Verpoorten et al., 2006b). Haplotype analysis suggested a common founder effect with previously described patients carrying this missense mutation (Indo et al., 2001).
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 175 211 175 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1, RAB7, WNK1/HSN2, NTRK1, NGFB</italic>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 408 438 408 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1, RAB7, WNK1/HSN2, NTRK1</italic>
###xml 831 835 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 840 846 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 910 919 910 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 924 929 924 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 1164 1168 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1173 1178 1173 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 1255 1264 1255 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 1277 1283 1277 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 1293 1300 1293 1300 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</label>
###xml 1300 1492 1300 1492 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">Overview of HSAN types with corresponding gene/locus, inheritance pattern, cardinal phenotypic features and references to the Online Mendelian Inheritance in Man (OMIM) database and literature</p>
###xml 1300 1492 1300 1492 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">Overview of HSAN types with corresponding gene/locus, inheritance pattern, cardinal phenotypic features and references to the Online Mendelian Inheritance in Man (OMIM) database and literature</p></caption>
###xml 1492 1496 1492 1496 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Type</th>
###xml 1496 1500 1496 1500 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene</th>
###xml 1500 1505 1500 1505 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Locus</th>
###xml 1505 1508 1505 1508 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Inh</th>
###xml 1508 1525 1508 1525 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Clinical features</th>
###xml 1525 1528 1525 1528 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AAO</th>
###xml 1528 1532 1528 1532 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">OMIM</th>
###xml 1532 1541 1532 1541 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Reference</th>
###xml 1492 1541 1492 1541 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Locus</th><th rowspan="1" colspan="1">Inh</th><th rowspan="1" colspan="1">Clinical features</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">OMIM</th><th rowspan="1" colspan="1">Reference</th></tr>
###xml 1492 1541 1492 1541 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Locus</th><th rowspan="1" colspan="1">Inh</th><th rowspan="1" colspan="1">Clinical features</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">OMIM</th><th rowspan="1" colspan="1">Reference</th></tr></thead>
###xml 1541 1547 1541 1547 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN I</td>
###xml 1547 1553 1547 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 1547 1553 1547 1553 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>SPTLC1</italic></td>
###xml 1553 1559 1553 1559 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">9q22.2</td>
###xml 1559 1561 1559 1561 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1697 1698 1697 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1697 1698 1697 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 1561 1698 1561 1698 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Predominant loss of pain and temperature sensation, preservation of vibration sense, lancinating pain, variable distal motor involvement<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 1703 1704 1703 1704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1698 1704 1698 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Adult<sup>a</sup></td>
###xml 1704 1710 1704 1710 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">162400</td>
###xml 1718 1723 1718 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1726 1730 1726 1730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">2001</xref>
###xml 1740 1745 1740 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1748 1752 1748 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">2001</xref>
###xml 1710 1752 1710 1752 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Bejaoui <italic>et al</italic>., <xref ref-type="bibr" rid="B5">2001</xref>; Dawkins <italic>et al</italic>., <xref ref-type="bibr" rid="B9">2001</xref></td>
###xml 1541 1752 1541 1752 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN I</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">9q22.2</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant loss of pain and temperature sensation, preservation of vibration sense, lancinating pain, variable distal motor involvement<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Adult<sup>a</sup></td><td rowspan="1" colspan="1">162400</td><td rowspan="1" colspan="1">Bejaoui <italic>et al</italic>., <xref ref-type="bibr" rid="B5">2001</xref>; Dawkins <italic>et al</italic>., <xref ref-type="bibr" rid="B9">2001</xref></td></tr>
###xml 1752 1759 1752 1759 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN IB</td>
###xml 1759 1766 1759 1766 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">unknown</td>
###xml 1766 1774 1766 1774 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3p24-p22</td>
###xml 1774 1776 1774 1776 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1776 1870 1776 1870 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Predominant sensory neuropathy with cough and gastroesophageal reflux, rarely foot ulcerations</td>
###xml 1870 1875 1870 1875 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Adult</td>
###xml 1875 1881 1875 1881 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">608088</td>
###xml 1885 1890 1885 1890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1893 1897 1893 1897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">2003</xref>
###xml 1881 1897 1881 1897 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Kok <italic>et al</italic>., <xref ref-type="bibr" rid="B22">2003</xref></td>
###xml 1752 1897 1752 1897 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN IB</td><td rowspan="1" colspan="1">unknown</td><td rowspan="1" colspan="1">3p24-p22</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant sensory neuropathy with cough and gastroesophageal reflux, rarely foot ulcerations</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">608088</td><td rowspan="1" colspan="1">Kok <italic>et al</italic>., <xref ref-type="bibr" rid="B22">2003</xref></td></tr>
###xml 1897 1902 1897 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CMT2B</td>
###xml 1902 1906 1902 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 1902 1906 1902 1906 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RAB7</italic></td>
###xml 1906 1912 1906 1912 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3q21.3</td>
###xml 1912 1914 1912 1914 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AD</td>
###xml 1914 2010 1914 2010 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Prominent distal motor involvement, sensory loss of all qualities, acro-mutilating complications</td>
###xml 2010 2015 2010 2015 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Adult</td>
###xml 2015 2021 2015 2021 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">600882</td>
###xml 2031 2036 2031 2036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2039 2043 2039 2043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 2021 2043 2021 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref></td>
###xml 1897 2043 1897 2043 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">3q21.3</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Prominent distal motor involvement, sensory loss of all qualities, acro-mutilating complications</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">600882</td><td rowspan="1" colspan="1">Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref></td></tr>
###xml 2043 2050 2043 2050 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN II</td>
###xml 2050 2059 2050 2059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 2050 2059 2050 2059 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>WNK1/HSN2</italic></td>
###xml 2059 2066 2059 2066 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">12p13.3</td>
###xml 2066 2068 2066 2068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR</td>
###xml 2068 2135 2068 2135 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Prominent sensory loss and mutilations in hands and feet, acropathy</td>
###xml 2135 2144 2135 2144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Childhood</td>
###xml 2144 2150 2144 2150 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">201300</td>
###xml 2161 2166 2161 2166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2169 2173 2169 2173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">2004</xref>
###xml 2150 2173 2150 2173 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Lafreniere <italic>et al</italic>., <xref ref-type="bibr" rid="B25">2004</xref></td>
###xml 2043 2173 2043 2173 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN II</td><td rowspan="1" colspan="1"><italic>WNK1/HSN2</italic></td><td rowspan="1" colspan="1">12p13.3</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory loss and mutilations in hands and feet, acropathy</td><td rowspan="1" colspan="1">Childhood</td><td rowspan="1" colspan="1">201300</td><td rowspan="1" colspan="1">Lafreniere <italic>et al</italic>., <xref ref-type="bibr" rid="B25">2004</xref></td></tr>
###xml 2173 2202 2173 2202 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN III (Riley&#8211;Day syndrome)</td>
###xml 2202 2208 2202 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKBKAP</italic>
###xml 2202 2208 2202 2208 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>IKBKAP</italic></td>
###xml 2208 2212 2208 2212 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">9q31</td>
###xml 2212 2214 2212 2214 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR</td>
###xml 2214 2363 2214 2363 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Familial dysautonomia, prominent autonomic disturbances and complications, absence of fungiform papillae of the tongue, alacrimia, excessive sweating</td>
###xml 2363 2373 2363 2373 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Congenital</td>
###xml 2373 2379 2373 2379 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">223900</td>
###xml 2392 2397 2392 2397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2400 2404 2400 2404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">2001</xref>
###xml 2379 2404 2379 2404 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Slaugenhaupt <italic>et al</italic>., <xref ref-type="bibr" rid="B35">2001</xref></td>
###xml 2173 2404 2173 2404 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN III (Riley&#8211;Day syndrome)</td><td rowspan="1" colspan="1"><italic>IKBKAP</italic></td><td rowspan="1" colspan="1">9q31</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Familial dysautonomia, prominent autonomic disturbances and complications, absence of fungiform papillae of the tongue, alacrimia, excessive sweating</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">223900</td><td rowspan="1" colspan="1">Slaugenhaupt <italic>et al</italic>., <xref ref-type="bibr" rid="B35">2001</xref></td></tr>
###xml 2404 2418 2404 2418 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN IV (CIPA)</td>
###xml 2418 2423 2418 2423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 2418 2423 2418 2423 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NTRK1</italic></td>
###xml 2423 2430 2423 2430 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1q21-22</td>
###xml 2430 2432 2430 2432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR</td>
###xml 2432 2621 2432 2621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No or reduced response to painful stimuli, anhidrosis, episodic fever, mild mental retardation, skin and cornea lesions, joint deformities, hypogammaglobulinemia in one patient (this study)</td>
###xml 2621 2631 2621 2631 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Congenital</td>
###xml 2631 2637 2631 2637 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">256800</td>
###xml 2642 2647 2642 2647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2650 2654 2650 2654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">1996</xref>
###xml 2637 2654 2637 2654 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Indo <italic>et al</italic>., <xref ref-type="bibr" rid="B18">1996</xref></td>
###xml 2404 2654 2404 2654 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN IV (CIPA)</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">1q21-22</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">No or reduced response to painful stimuli, anhidrosis, episodic fever, mild mental retardation, skin and cornea lesions, joint deformities, hypogammaglobulinemia in one patient (this study)</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">256800</td><td rowspan="1" colspan="1">Indo <italic>et al</italic>., <xref ref-type="bibr" rid="B18">1996</xref></td></tr>
###xml 2654 2660 2654 2660 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN V</td>
###xml 2660 2664 2660 2664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 2666 2671 2666 2671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 2660 2686 2660 2686 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>NGFB</italic> (<italic>NTRK1</italic> in rare cases)</td>
###xml 2686 2702 2686 2702 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1p13.1 (1q21-22)</td>
###xml 2702 2704 2702 2704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR</td>
###xml 2704 2833 2704 2833 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Congenital insensitivity to pain, severe loss of deep pain perception, painless fractures, joint deformities, normal intelligence</td>
###xml 2833 2843 2833 2843 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Congenital</td>
###xml 2843 2849 2843 2849 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">608654</td>
###xml 2862 2867 2862 2867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2870 2874 2870 2874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">2004</xref>
###xml 2884 2889 2884 2889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2892 2896 2892 2896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">2001</xref>
###xml 2849 2897 2849 2897 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Einarsdottir <italic>et al</italic>., <xref ref-type="bibr" rid="B11">2004</xref> (Houlden <italic>et al</italic>., <xref ref-type="bibr" rid="B15">2001</xref>)</td>
###xml 2654 2897 2654 2897 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN V</td><td rowspan="1" colspan="1"><italic>NGFB</italic> (<italic>NTRK1</italic> in rare cases)</td><td rowspan="1" colspan="1">1p13.1 (1q21-22)</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Congenital insensitivity to pain, severe loss of deep pain perception, painless fractures, joint deformities, normal intelligence</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">608654</td><td rowspan="1" colspan="1">Einarsdottir <italic>et al</italic>., <xref ref-type="bibr" rid="B11">2004</xref> (Houlden <italic>et al</italic>., <xref ref-type="bibr" rid="B15">2001</xref>)</td></tr>
###xml 2897 2925 2897 2925 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HSAN with spastic paraplegia</td>
###xml 2925 2929 2925 2929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 2925 2929 2925 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>CCT5</italic></td>
###xml 2929 2937 2929 2937 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5p15-p14</td>
###xml 2937 2939 2937 2939 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AR</td>
###xml 2939 3045 2939 3045 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Prominent sensory neuropathy with sensory loss of all qualities, mutilating acropathy, spastic paraplegia.</td>
###xml 3045 3060 3045 3060 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Early childhood</td>
###xml 3060 3066 3060 3066 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">256840</td>
###xml 3076 3081 3076 3081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 3088 3089 3088 3089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 3084 3089 3084 3089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">2006<italic>a</italic></xref>
###xml 3066 3089 3066 3089 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Bouhouche <italic>et al</italic>., <xref ref-type="bibr" rid="B6">2006<italic>a</italic></xref></td>
###xml 2897 3089 2897 3089 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HSAN with spastic paraplegia</td><td rowspan="1" colspan="1"><italic>CCT5</italic></td><td rowspan="1" colspan="1">5p15-p14</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory neuropathy with sensory loss of all qualities, mutilating acropathy, spastic paraplegia.</td><td rowspan="1" colspan="1">Early childhood</td><td rowspan="1" colspan="1">256840</td><td rowspan="1" colspan="1">Bouhouche <italic>et al</italic>., <xref ref-type="bibr" rid="B6">2006<italic>a</italic></xref></td></tr>
###xml 1541 3089 1541 3089 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">HSAN I</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">9q22.2</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant loss of pain and temperature sensation, preservation of vibration sense, lancinating pain, variable distal motor involvement<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Adult<sup>a</sup></td><td rowspan="1" colspan="1">162400</td><td rowspan="1" colspan="1">Bejaoui <italic>et al</italic>., <xref ref-type="bibr" rid="B5">2001</xref>; Dawkins <italic>et al</italic>., <xref ref-type="bibr" rid="B9">2001</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN IB</td><td rowspan="1" colspan="1">unknown</td><td rowspan="1" colspan="1">3p24-p22</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant sensory neuropathy with cough and gastroesophageal reflux, rarely foot ulcerations</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">608088</td><td rowspan="1" colspan="1">Kok <italic>et al</italic>., <xref ref-type="bibr" rid="B22">2003</xref></td></tr><tr><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">3q21.3</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Prominent distal motor involvement, sensory loss of all qualities, acro-mutilating complications</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">600882</td><td rowspan="1" colspan="1">Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN II</td><td rowspan="1" colspan="1"><italic>WNK1/HSN2</italic></td><td rowspan="1" colspan="1">12p13.3</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory loss and mutilations in hands and feet, acropathy</td><td rowspan="1" colspan="1">Childhood</td><td rowspan="1" colspan="1">201300</td><td rowspan="1" colspan="1">Lafreniere <italic>et al</italic>., <xref ref-type="bibr" rid="B25">2004</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN III (Riley&#8211;Day syndrome)</td><td rowspan="1" colspan="1"><italic>IKBKAP</italic></td><td rowspan="1" colspan="1">9q31</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Familial dysautonomia, prominent autonomic disturbances and complications, absence of fungiform papillae of the tongue, alacrimia, excessive sweating</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">223900</td><td rowspan="1" colspan="1">Slaugenhaupt <italic>et al</italic>., <xref ref-type="bibr" rid="B35">2001</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN IV (CIPA)</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">1q21-22</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">No or reduced response to painful stimuli, anhidrosis, episodic fever, mild mental retardation, skin and cornea lesions, joint deformities, hypogammaglobulinemia in one patient (this study)</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">256800</td><td rowspan="1" colspan="1">Indo <italic>et al</italic>., <xref ref-type="bibr" rid="B18">1996</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN V</td><td rowspan="1" colspan="1"><italic>NGFB</italic> (<italic>NTRK1</italic> in rare cases)</td><td rowspan="1" colspan="1">1p13.1 (1q21-22)</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Congenital insensitivity to pain, severe loss of deep pain perception, painless fractures, joint deformities, normal intelligence</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">608654</td><td rowspan="1" colspan="1">Einarsdottir <italic>et al</italic>., <xref ref-type="bibr" rid="B11">2004</xref> (Houlden <italic>et al</italic>., <xref ref-type="bibr" rid="B15">2001</xref>)</td></tr><tr><td rowspan="1" colspan="1">HSAN with spastic paraplegia</td><td rowspan="1" colspan="1"><italic>CCT5</italic></td><td rowspan="1" colspan="1">5p15-p14</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory neuropathy with sensory loss of all qualities, mutilating acropathy, spastic paraplegia.</td><td rowspan="1" colspan="1">Early childhood</td><td rowspan="1" colspan="1">256840</td><td rowspan="1" colspan="1">Bouhouche <italic>et al</italic>., <xref ref-type="bibr" rid="B6">2006<italic>a</italic></xref></td></tr></tbody>
###xml 1492 3089 1492 3089 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Locus</th><th rowspan="1" colspan="1">Inh</th><th rowspan="1" colspan="1">Clinical features</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">OMIM</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">HSAN I</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">9q22.2</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant loss of pain and temperature sensation, preservation of vibration sense, lancinating pain, variable distal motor involvement<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Adult<sup>a</sup></td><td rowspan="1" colspan="1">162400</td><td rowspan="1" colspan="1">Bejaoui <italic>et al</italic>., <xref ref-type="bibr" rid="B5">2001</xref>; Dawkins <italic>et al</italic>., <xref ref-type="bibr" rid="B9">2001</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN IB</td><td rowspan="1" colspan="1">unknown</td><td rowspan="1" colspan="1">3p24-p22</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant sensory neuropathy with cough and gastroesophageal reflux, rarely foot ulcerations</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">608088</td><td rowspan="1" colspan="1">Kok <italic>et al</italic>., <xref ref-type="bibr" rid="B22">2003</xref></td></tr><tr><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">3q21.3</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Prominent distal motor involvement, sensory loss of all qualities, acro-mutilating complications</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">600882</td><td rowspan="1" colspan="1">Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN II</td><td rowspan="1" colspan="1"><italic>WNK1/HSN2</italic></td><td rowspan="1" colspan="1">12p13.3</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory loss and mutilations in hands and feet, acropathy</td><td rowspan="1" colspan="1">Childhood</td><td rowspan="1" colspan="1">201300</td><td rowspan="1" colspan="1">Lafreniere <italic>et al</italic>., <xref ref-type="bibr" rid="B25">2004</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN III (Riley&#8211;Day syndrome)</td><td rowspan="1" colspan="1"><italic>IKBKAP</italic></td><td rowspan="1" colspan="1">9q31</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Familial dysautonomia, prominent autonomic disturbances and complications, absence of fungiform papillae of the tongue, alacrimia, excessive sweating</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">223900</td><td rowspan="1" colspan="1">Slaugenhaupt <italic>et al</italic>., <xref ref-type="bibr" rid="B35">2001</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN IV (CIPA)</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">1q21-22</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">No or reduced response to painful stimuli, anhidrosis, episodic fever, mild mental retardation, skin and cornea lesions, joint deformities, hypogammaglobulinemia in one patient (this study)</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">256800</td><td rowspan="1" colspan="1">Indo <italic>et al</italic>., <xref ref-type="bibr" rid="B18">1996</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN V</td><td rowspan="1" colspan="1"><italic>NGFB</italic> (<italic>NTRK1</italic> in rare cases)</td><td rowspan="1" colspan="1">1p13.1 (1q21-22)</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Congenital insensitivity to pain, severe loss of deep pain perception, painless fractures, joint deformities, normal intelligence</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">608654</td><td rowspan="1" colspan="1">Einarsdottir <italic>et al</italic>., <xref ref-type="bibr" rid="B11">2004</xref> (Houlden <italic>et al</italic>., <xref ref-type="bibr" rid="B15">2001</xref>)</td></tr><tr><td rowspan="1" colspan="1">HSAN with spastic paraplegia</td><td rowspan="1" colspan="1"><italic>CCT5</italic></td><td rowspan="1" colspan="1">5p15-p14</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory neuropathy with sensory loss of all qualities, mutilating acropathy, spastic paraplegia.</td><td rowspan="1" colspan="1">Early childhood</td><td rowspan="1" colspan="1">256840</td><td rowspan="1" colspan="1">Bouhouche <italic>et al</italic>., <xref ref-type="bibr" rid="B6">2006<italic>a</italic></xref></td></tr></tbody></table>
###xml 3089 3200 3089 3200 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">a Congenital onset in one patient with hypotonia, cataract, microcephaly and vocal cord paralysis (this study).</p>
###xml 3089 3200 3089 3200 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="42">a Congenital onset in one patient with hypotonia, cataract, microcephaly and vocal cord paralysis (this study).</p></fn>
###xml 3267 3272 3267 3272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 3275 3279 3275 3279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">2006</xref>
###xml 3294 3299 3294 3299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 3302 3306 3302 3306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">2006</xref>
###xml 3200 3308 3200 3308 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">Inh = inheritance; AAO = age at onset; (updated from Auer-Grumbach <italic>et al</italic>., <xref ref-type="bibr" rid="B3">2006</xref> and Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B41">2006</xref>).</p>
###xml 3200 3308 3200 3308 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">Inh = inheritance; AAO = age at onset; (updated from Auer-Grumbach <italic>et al</italic>., <xref ref-type="bibr" rid="B3">2006</xref> and Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B41">2006</xref>).</p></fn>
###xml 3089 3308 3089 3308 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="42">a Congenital onset in one patient with hypotonia, cataract, microcephaly and vocal cord paralysis (this study).</p></fn><fn><p textid="43">Inh = inheritance; AAO = age at onset; (updated from Auer-Grumbach <italic>et al</italic>., <xref ref-type="bibr" rid="B3">2006</xref> and Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B41">2006</xref>).</p></fn></table-wrap-foot>
###xml 1293 3308 1293 3308 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p textid="41">Overview of HSAN types with corresponding gene/locus, inheritance pattern, cardinal phenotypic features and references to the Online Mendelian Inheritance in Man (OMIM) database and literature</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Locus</th><th rowspan="1" colspan="1">Inh</th><th rowspan="1" colspan="1">Clinical features</th><th rowspan="1" colspan="1">AAO</th><th rowspan="1" colspan="1">OMIM</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">HSAN I</td><td rowspan="1" colspan="1"><italic>SPTLC1</italic></td><td rowspan="1" colspan="1">9q22.2</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant loss of pain and temperature sensation, preservation of vibration sense, lancinating pain, variable distal motor involvement<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">Adult<sup>a</sup></td><td rowspan="1" colspan="1">162400</td><td rowspan="1" colspan="1">Bejaoui <italic>et al</italic>., <xref ref-type="bibr" rid="B5">2001</xref>; Dawkins <italic>et al</italic>., <xref ref-type="bibr" rid="B9">2001</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN IB</td><td rowspan="1" colspan="1">unknown</td><td rowspan="1" colspan="1">3p24-p22</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Predominant sensory neuropathy with cough and gastroesophageal reflux, rarely foot ulcerations</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">608088</td><td rowspan="1" colspan="1">Kok <italic>et al</italic>., <xref ref-type="bibr" rid="B22">2003</xref></td></tr><tr><td rowspan="1" colspan="1">CMT2B</td><td rowspan="1" colspan="1"><italic>RAB7</italic></td><td rowspan="1" colspan="1">3q21.3</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">Prominent distal motor involvement, sensory loss of all qualities, acro-mutilating complications</td><td rowspan="1" colspan="1">Adult</td><td rowspan="1" colspan="1">600882</td><td rowspan="1" colspan="1">Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B39">2003</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN II</td><td rowspan="1" colspan="1"><italic>WNK1/HSN2</italic></td><td rowspan="1" colspan="1">12p13.3</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory loss and mutilations in hands and feet, acropathy</td><td rowspan="1" colspan="1">Childhood</td><td rowspan="1" colspan="1">201300</td><td rowspan="1" colspan="1">Lafreniere <italic>et al</italic>., <xref ref-type="bibr" rid="B25">2004</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN III (Riley&#8211;Day syndrome)</td><td rowspan="1" colspan="1"><italic>IKBKAP</italic></td><td rowspan="1" colspan="1">9q31</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Familial dysautonomia, prominent autonomic disturbances and complications, absence of fungiform papillae of the tongue, alacrimia, excessive sweating</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">223900</td><td rowspan="1" colspan="1">Slaugenhaupt <italic>et al</italic>., <xref ref-type="bibr" rid="B35">2001</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN IV (CIPA)</td><td rowspan="1" colspan="1"><italic>NTRK1</italic></td><td rowspan="1" colspan="1">1q21-22</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">No or reduced response to painful stimuli, anhidrosis, episodic fever, mild mental retardation, skin and cornea lesions, joint deformities, hypogammaglobulinemia in one patient (this study)</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">256800</td><td rowspan="1" colspan="1">Indo <italic>et al</italic>., <xref ref-type="bibr" rid="B18">1996</xref></td></tr><tr><td rowspan="1" colspan="1">HSAN V</td><td rowspan="1" colspan="1"><italic>NGFB</italic> (<italic>NTRK1</italic> in rare cases)</td><td rowspan="1" colspan="1">1p13.1 (1q21-22)</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Congenital insensitivity to pain, severe loss of deep pain perception, painless fractures, joint deformities, normal intelligence</td><td rowspan="1" colspan="1">Congenital</td><td rowspan="1" colspan="1">608654</td><td rowspan="1" colspan="1">Einarsdottir <italic>et al</italic>., <xref ref-type="bibr" rid="B11">2004</xref> (Houlden <italic>et al</italic>., <xref ref-type="bibr" rid="B15">2001</xref>)</td></tr><tr><td rowspan="1" colspan="1">HSAN with spastic paraplegia</td><td rowspan="1" colspan="1"><italic>CCT5</italic></td><td rowspan="1" colspan="1">5p15-p14</td><td rowspan="1" colspan="1">AR</td><td rowspan="1" colspan="1">Prominent sensory neuropathy with sensory loss of all qualities, mutilating acropathy, spastic paraplegia.</td><td rowspan="1" colspan="1">Early childhood</td><td rowspan="1" colspan="1">256840</td><td rowspan="1" colspan="1">Bouhouche <italic>et al</italic>., <xref ref-type="bibr" rid="B6">2006<italic>a</italic></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p textid="42">a Congenital onset in one patient with hypotonia, cataract, microcephaly and vocal cord paralysis (this study).</p></fn><fn><p textid="43">Inh = inheritance; AAO = age at onset; (updated from Auer-Grumbach <italic>et al</italic>., <xref ref-type="bibr" rid="B3">2006</xref> and Verhoeven <italic>et al</italic>., <xref ref-type="bibr" rid="B41">2006</xref>).</p></fn></table-wrap-foot></table-wrap>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
###xml 563 571 <span type="species:ncbi:9606">patients</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
###xml 740 748 <span type="species:ncbi:9606">patients</span>
###xml 778 786 <span type="species:ncbi:9606">patients</span>
###xml 984 992 <span type="species:ncbi:9606">patients</span>
###xml 1375 1383 <span type="species:ncbi:405018">cardinal</span>
###xml 1458 1461 <span type="species:ncbi:9606">Man</span>
###xml 1463 1467 <span type="species:ncbi:9606">OMIM</span>
###xml 2601 2608 <span type="species:ncbi:9606">patient</span>
###xml 3115 3122 <span type="species:ncbi:9606">patient</span>
In this study, we investigated a cohort of 100 HSAN patients and determined the relative contribution of mutations in six genes known to be involved in various forms of HSAN (SPTLC1, RAB7, WNK1/HSN2, NTRK1, NGFB and CCT5). In addition, we studied the functional candidate gene NGFR. The known subforms of HSAN and their most important clinical characteristics have been summarized in Table 3. In four genes (SPTLC1, RAB7, WNK1/HSN2, NTRK1), we identified disease-causing mutations in 19 index patients representing a mutation frequency of 19%. Only nine of these patients had a clear familial history suggestive of HSAN with the remaining 10 being isolated patients. This results in a relative mutation frequency of 31% (9/29) for familial patients and 14% (10/71) for isolated patients. In the group of dominantly inherited HSAN (RAB7 and SPTLC1), the mutation frequency is 33% (7/21) and for recessive HSAN (WNK1/HSN2 and NTRK1), the frequency is 25% (2/8). Conversely, 20 familial patients in our screening cohort (14 dominant and 6 recessive) remain unsolved. These findings clearly indicate that additional genes must be involved in the pathogenesis of HSAN. RAB7 and NTRK1 were the most frequently mutated genes in our cohort (both 7%), followed by WNK1/HSN2 with 3% and SPTLC1 with 2%. Table 3Overview of HSAN types with corresponding gene/locus, inheritance pattern, cardinal phenotypic features and references to the Online Mendelian Inheritance in Man (OMIM) database and literatureTypeGeneLocusInhClinical featuresAAOOMIMReferenceHSAN ISPTLC19q22.2ADPredominant loss of pain and temperature sensation, preservation of vibration sense, lancinating pain, variable distal motor involvementaAdulta162400Bejaoui et al., 2001; Dawkins et al., 2001HSAN IBunknown3p24-p22ADPredominant sensory neuropathy with cough and gastroesophageal reflux, rarely foot ulcerationsAdult608088Kok et al., 2003CMT2BRAB73q21.3ADProminent distal motor involvement, sensory loss of all qualities, acro-mutilating complicationsAdult600882Verhoeven et al., 2003HSAN IIWNK1/HSN212p13.3ARProminent sensory loss and mutilations in hands and feet, acropathyChildhood201300Lafreniere et al., 2004HSAN III (Riley-Day syndrome)IKBKAP9q31ARFamilial dysautonomia, prominent autonomic disturbances and complications, absence of fungiform papillae of the tongue, alacrimia, excessive sweatingCongenital223900Slaugenhaupt et al., 2001HSAN IV (CIPA)NTRK11q21-22ARNo or reduced response to painful stimuli, anhidrosis, episodic fever, mild mental retardation, skin and cornea lesions, joint deformities, hypogammaglobulinemia in one patient (this study)Congenital256800Indo et al., 1996HSAN VNGFB (NTRK1 in rare cases)1p13.1 (1q21-22)ARCongenital insensitivity to pain, severe loss of deep pain perception, painless fractures, joint deformities, normal intelligenceCongenital608654Einarsdottir et al., 2004 (Houlden et al., 2001)HSAN with spastic paraplegiaCCT55p15-p14ARProminent sensory neuropathy with sensory loss of all qualities, mutilating acropathy, spastic paraplegia.Early childhood256840Bouhouche et al., 2006aa Congenital onset in one patient with hypotonia, cataract, microcephaly and vocal cord paralysis (this study).Inh = inheritance; AAO = age at onset; (updated from Auer-Grumbach et al., 2006 and Verhoeven et al., 2006).
###end p 40
###begin p 41
###xml 75 83 <span type="species:ncbi:405018">cardinal</span>
###xml 158 161 <span type="species:ncbi:9606">Man</span>
###xml 163 167 <span type="species:ncbi:9606">OMIM</span>
Overview of HSAN types with corresponding gene/locus, inheritance pattern, cardinal phenotypic features and references to the Online Mendelian Inheritance in Man (OMIM) database and literature
###end p 41
###begin p 42
###xml 26 33 <span type="species:ncbi:9606">patient</span>
a Congenital onset in one patient with hypotonia, cataract, microcephaly and vocal cord paralysis (this study).
###end p 42
###begin p 43
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">2006</xref>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">2006</xref>
Inh = inheritance; AAO = age at onset; (updated from Auer-Grumbach et al., 2006 and Verhoeven et al., 2006).
###end p 43
###begin p 44
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">2001</xref>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">2001</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">2004</xref>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2006</xref>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">2004</xref>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2009</xref>
The three mutations previously described in SPTLC1 (Cys133Trp, Cys133Tyr and Val144Asp) are associated with an ulcero-mutilating sensory neuropathy with a spectrum of clinical and electrophysiological features that is variable within and between families (Bejaoui et al., 2001; Dawkins et al., 2001; Auer-Grumbach, 2004; Houlden et al., 2006). A fourth SPTLC1 mutation (Gly387Ala) was recently shown not to be disease causing (Verhoeven et al., 2004; Hornemann et al., 2009).
###end p 44
###begin p 45
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 357 363 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 427 433 427 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 740 746 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 75 82 <span type="species:ncbi:9606">patient</span>
###xml 763 770 <span type="species:ncbi:9606">patient</span>
In the present study, we describe a novel SPTLC1 mutation (Ser331Phe) in a patient who presented with a severe congenital phenotype. This mutation occurred de novo, was absent from 600 control chromosomes and affected a highly conserved amino acid. So far, all known missense mutations are located within a 12-amino acid segment encoded by exons 5 and 6 of SPTLC1. The Ser331Phe mutation is located downstream of this segment (Fig. 2). It is possible that the Ser331Phe mutation, due to its different location in the protein, exerts a different effect on SPT activity leading to a more severe phenotype. These results suggest a broadening of the phenotype associated with HSAN type I. We identified a second sequence variant (Ala352Val) in SPTLC1, in an isolated patient with a sensory neuropathy. However, the pathogenicity of this sequence variant could not be verified because DNA of the family members was not available for segregation analysis. Furthermore, the amino acid targeted is not well-conserved in evolution and the change from alanine to valine is mild considering their similar chemical properties.
###end p 45
###begin p 46
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">2005</xref>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2006</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
We found mutations in SPTLC1 in only 2% of our patients confirming the rare occurrence of SPTLC1 mutations in isolated and familial HSAN, as found in previous studies (Klein et al., 2005; Houlden et al., 2006).
###end p 46
###begin p 47
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 149 154 149 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">2004<italic>b</italic></xref>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2006</xref>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2003</xref>
###xml 816 820 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 945 951 945 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1165 1170 1165 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1177 1178 1177 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1173 1178 1173 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">2004<italic>b</italic></xref>
###xml 1188 1193 1188 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1196 1200 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2006</xref>
###xml 281 288 <span type="species:ncbi:9606">Patient</span>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
###xml 630 638 <span type="species:ncbi:9606">patients</span>
###xml 1136 1144 <span type="species:ncbi:9606">patients</span>
To date, four missense mutations (Leu129Phe, Lys157Asn, Asn161Thr and Val162Met) have been reported in RAB7 (Verhoeven et al., 2003; Houlden et al., 2004b; Meggouh et al., 2006). In our cohort, we found the Leu129Phe mutation in two families (CMT-126 and CMT-140) and one isolated Patient (CMT-186.26), and the Val162Met mutation in families CMT-90 and CMT-195 and in two additional patients with a positive family history (CMT-186.28 and PN626.01) (Verhoeven et al., 2003). The patients carrying the Leu129Phe mutation were all of Austrian descent and shared a common disease haplotype, indicating a founder effect. However, the patients with the Val162Met mutation did not share a common haplotype, suggesting independently arising mutations in the same residue, possibly pointing towards a mutational hotspot for RAB7. This mutation is located in a highly conserved domain, important for the formation of the nucleotide-binding site of RAB7 (Fig. 2). The functional importance of this domain in peripheral neuron integrity is further underlined by the identification of mutations in adjacent amino acids (Lys157Asn and Asn161Thr) in patients with CMT2B (Houlden et al., 2004b; Meggouh et al., 2006).
###end p 47
###begin p 48
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 268 273 268 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">2004<italic>b</italic></xref>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">1995</xref>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">1996</xref>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 169 176 <span type="species:ncbi:9606">patient</span>
In our cohort, RAB7 mutations were exclusively found in patients diagnosed with HSMN II, with ulcero-mutilations also known as CMT2B. Apart from the rare exception of a patient with a typical HSAN type I phenotype carrying the Asn161Thr RAB7 mutation (Houlden et al., 2004b), the phenotype associated with RAB7 mutations seems to be largely confined to HMSN II (CMT2B). Because of the marked motor involvement, RAB7-neuropathy was originally classified as hereditary motor and sensory neuropathy type 2B (CMT2B) (Kwon et al., 1995). Due to the prominent presence of ulcerations, however, CMT2B should be considered part of the spectrum of HSAN (Vance et al., 1996).
###end p 48
###begin p 49
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">2005</xref>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 417 425 <span type="species:ncbi:9606">patients</span>
The mutation frequency in the CMT2B-subgroup of our study cohort was very high (7 out of 13 CMT2B patients). The high mutation frequency of RAB7 found in the present study contrasts with a previous report (Klein et al., 2005), where the known RAB7 mutations were shown to be absent from a group of 25 families with adult-onset HSAN I or HMSN II with prominent sensory involvement and from an additional 92 idiopathic patients. The frequency of the RAB7 mutation in our cohort remained high, even when the founder effect of the Leu129Phe mutation was taken into account.
###end p 49
###begin p 50
###xml 43 52 43 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">2007</xref>
###xml 263 272 263 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">2008</xref>
###xml 654 663 654 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 723 729 723 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 737 742 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2006</xref>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1</italic>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSN2</italic>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
###xml 805 813 <span type="species:ncbi:9606">patients</span>
The phenotype associated with mutations in WNK1/HSN2 is a severe AR ulcero-mutilating sensory neuropathy with mild autonomic disturbances beginning in early childhood (Axelrod and Gold-von Simson, 2007). So far, 11 different non-sense and frameshift mutations in WNK1/HSN2 have been reported in the literature, all resulting in a complete loss of protein. Recently, it was shown that HSN2 is not a separate gene residing in intron 8 of WNK1 but in fact is a neuron-specific exon of WNK1 itself, with high expression in dorsal root ganglia (DRG) and sciatic nerves (Shekarabi et al., 2008). In our cohort, we identified four loss-of-function mutations in WNK1/HSN2, in three patients, all of which resided in the HSN2 exon (Fig. 2) (Coen et al., 2006). From the first large-scale screening of WNK1 in HSAN patients performed in this study, we can conclude that mutations outside of the HSN2 exon are likely to be rare.
###end p 50
###begin p 51
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">1987</xref>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">2007</xref>
The most frequently mutated gene in this study, together with RAB7, was NTRK1. The NTRK1 protein is a receptor tyrosine kinase, which is phosphorylated in response to nerve growth factor (NGF), supporting survival of sympathetic ganglion neurons and nociceptive sensory neurons in DRG (Levi-Montalcini, 1987). To date, more than 40 different missense, non-sense, frameshift and splice site mutations in NTRK1 have been described in families from various ethnic origins (). The corresponding syndrome, CIPA, consists of characteristic features: recurrent episodic fevers due to anhidrosis, absence of reaction to painful stimuli, self-mutilating behaviour and mental retardation (Axelrod and Gold-von Simson, 2007).
###end p 51
###begin p 52
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 88 94 88 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 155 160 155 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">2006<italic>b</italic></xref>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">2009</xref>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 832 837 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2007</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 519 526 <span type="species:ncbi:9606">patient</span>
###xml 653 660 <span type="species:ncbi:9606">Patient</span>
###xml 786 794 <span type="species:ncbi:9606">patients</span>
In our cohort of 100 HSAN patients, seven different mutations were identified in NTRK1 (Fig. 2), of which six were previously reported (Verpoorten et al., 2006b; Kilic et al., 2009). We identified a previously unreported splice site mutation (Arg565Gln), which comprised the last nucleotide of exon 14 and further broadens the genetic spectrum of NTRK1 mutations. This mutation resides in the tyrosine kinase domain of the NTRK1 receptor, which regulates autophosphorylation of NTRK1 in response to NGF. Both the index patient (CMT-841.01) and her affected sister (CMT-841.02) were diagnosed with CIPA and carried the same homozygous mutation. However, Patient CMT-841.01 had a normal intelligence whereas the affected sib (CMT-841.02) had learning difficulties. The phenotype of these patients has been described previously (Kruyt et al., 2007).
###end p 52
###begin p 53
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">2009</xref>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2008</xref>
###xml 134 141 <span type="species:ncbi:9606">patient</span>
###xml 179 186 <span type="species:ncbi:9606">patient</span>
###xml 423 430 <span type="species:ncbi:9606">patient</span>
###xml 562 569 <span type="species:ncbi:9606">patient</span>
Interestingly, a 9-bp deletion (c.354_359 + 3delTCGCCTGAA), resulting in skipping of exon 3 and of exons 2 and 3, was found in a CIPA patient of Turkish origin (CMT-860.01). This patient presented with a multisystem involvement including recurrent infections due to immunological abnormalities as hypogammaglobulinemia (Kilic et al., 2009). The same 9-bp deletion was recently reported in an unrelated Turkish HSAN type IV patient (Tuysuz et al., 2008). Therefore, this mutation is likely to be a founder mutation in the Turkish population. The phenotype in our patient broadens the clinical spectrum of CIPA.
###end p 53
###begin p 54
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">2001</xref>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
It has previously been suggested (Indo et al., 2001) that the current literature reveals little to no genetic and clinical heterogeneity in HSAN IV. Although some degree of phenotypic variability was observed in our CIPA-patients with proven NTRK1 mutations, overall the clinical presentation seems to correspond to a readily recognizable syndrome that is indeed genetically homogenous.
###end p 54
###begin p 55
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">2004</xref>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">2004</xref>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">2009</xref>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">2001</xref>
###xml 713 714 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 709 714 709 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">2004<italic>a</italic></xref>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 961 965 961 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 984 992 <span type="species:ncbi:9606">patients</span>
The phenotype caused by NGFB mutations (HSAN type V) is similar to the CIPA phenotype (HSAN type IV). So far, only one homozygous missense mutation has been reported, in a recessive Swedish family (Einarsdottir et al., 2004; Minde et al., 2004). Detailed clinical, neurophysiological and genetic analysis of this family revealed that the heterozygous carriers presented with a variable but mild phenotype (Minde et al., 2009). The main difference with CIPA was the absence of obvious mental retardation and less-pronounced anhidrosis. However, one family with the HSAN type V phenotype was described with pathogenic mutations in NTRK1 indicating the overlap between HSAN types IV and V (Houlden et al., 2001, 2004a). These findings underscore the relevance of genetic screenings outside of the known phenotypes and modes of inheritance. In our study cohort, no heterozygous or homozygous sequence variations were found in NGFB confirming the rare occurrence of NGFB mutations in HSAN patients.
###end p 55
###begin p 56
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 144 149 144 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">2006<italic>a</italic></xref>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
Recessive mutations in CCT5 were identified in a consanguineous Moroccan family presenting with HSAN with spastic paraplegia (Bouhouche et al., 2006a). In our cohort, only two HSAN patients presented with an associated spastic paraplegia. However, we did not identify mutations in CCT5. Additional screening of 25 unrelated index patients with hereditary spastic paraplegia with sensory involvement did not reveal any mutations in CCT5 (data not shown). Our results suggest that mutations in CCT5 are a rare cause for HSAN and make it unlikely to find any mutations outside of the known phenotype.
###end p 56
###begin p 57
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p75/NTR</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">1992</xref>
###xml 85 89 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 95 102 <span type="species:ncbi:9606">patient</span>
Because of the phenotypical resemblance among Ntrk1-/-, Ngfb-/- and Ngfr-/- knockout mice, the patient cohort was screened for NGFR (p75/NTR) (Lee et al., 1992). No mutations were found in this gene making its contribution to the pathogenesis of HSAN uncertain.
###end p 57
###begin p 58
###xml 299 313 299 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo SPTLC1</italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTRK1</italic>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB7</italic>
###xml 884 893 884 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNK1/HSN2</italic>
###xml 898 904 898 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPTLC1</italic>
###xml 955 959 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFB</italic>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCT5</italic>
###xml 1114 1118 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</italic>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 549 557 <span type="species:ncbi:9606">patients</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
###xml 713 721 <span type="species:ncbi:9606">patients</span>
In summary, we examined the distribution of mutations in genes associated with AD and AR forms of HSAN in a large group of familial and sporadic patients. The genotype-phenotype correlations in this study revealed little variability when compared with previous reports, with the sole exception of a de novo SPTLC1 mutation in a severe phenotype with congenital onset. Taken together, these results show that the relevant clinical phenotypes are recognizable and should be used to orient molecular diagnosis. Screening of NTRK1 should be confined to patients presenting with a CIPA phenotype (both AR and isolated patients) as no NTRK1 mutations were found in other HSAN phenotypes. RAB7 screening is mandatory in patients presenting with an AD axonal sensory-motor neuropathy with ulcerations (CMT2B) as we found a high mutation frequency in this subgroup (54% or 7/13). Mutations in WNK1/HSN2 and SPTLC1 seem to be rare in HSAN. We found no mutations in NGFB and CCT5 indicating that these genes are only rarely involved in HSAN. No pathogenic sequence variations were identified in the functional candidate gene NGFR, making its contribution to the pathogenesis of HSAN uncertain. The overall mutation rate was relatively low (19%) suggesting that other genes must be involved in the pathogenesis of HSAN.
###end p 58
###begin p 59
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">2006</xref>
At the present time, the precise nature of the mechanism underlying the pathogenesis of the various HSAN forms remains unclear. Although it is particularly challenging to link the different genes, some preliminary disease pathways may already take form. Of special interest are disturbances of vesicular transport. Both RAB7 and SPTLC1 have a function in endocytotic membrane trafficking. In addition, the NGFB/NTRK1 signalling complex, which is critically important in the development and function of nociceptive neurons, is also dependent upon retrograde transport through signalling endosomes (Verhoeven et al., 2006). Future research is needed to improve our still very incomplete understanding of these mechanisms.
###end p 59
###begin p 60
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Additional descriptions of HSAN families and patients with known or novel genetic defects are needed to further refine the existing classification and to get a better insight into the molecular basis of these disorders.
###end p 60
###begin title 61
Funding
###end title 61
###begin p 62
University of Antwerp; the Fund for Scientific Research (FWO-Flanders); the Medical Foundation Queen Elisabeth (GSKE); the 'Association Belge contre les Maladies Neuromusculaires' (ABMM); the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office (BELSPO); the IZKF RWTH Aachen (TV M3); the German Research Council (DFG; WE1406/13-1); Austrian Science Fond (FWF; P19455-B05); PhD fellowships of the Institute for Science and Technology (IWT; to A.R.) and FWO-Flanders (J.B.).
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
###xml 23 31 <span type="species:ncbi:9606">patients</span>
We are grateful to the patients and their families for their willingness to co-operate in our research project. We also wish to thank the Genetic Service Facility (VIB) for the sequencing support ().
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
Hereditary sensory neuropathies
###end article-title 66
###begin article-title 67
Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review
###end article-title 67
###begin article-title 68
Molecular genetics of hereditary sensory neuropathies
###end article-title 68
###begin article-title 69
Hereditary sensory and autonomic neuropathies: types II, III, and IV
###end article-title 69
###begin article-title 70
SPTLC1 is mutated in hereditary sensory neuropathy, type 1
###end article-title 70
###begin article-title 71
Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia
###end article-title 71
###begin article-title 72
Autosomal recessive mutilating sensory neuropathy with spastic paraplegia maps to chromosome 5p15.31-14.1
###end article-title 72
###begin article-title 73
Novel mutations in the HSN2 gene causing hereditary sensory and autonomic neuropathy type II
###end article-title 73
###begin article-title 74
Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I
###end article-title 74
###begin article-title 75
Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons
###end article-title 75
###begin article-title 76
A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception
###end article-title 76
###begin article-title 77
A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated
###end article-title 77
###begin article-title 78
Hereditary sensory neuropathies
###end article-title 78
###begin article-title 79
Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I)
###end article-title 79
###begin article-title 80
A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V
###end article-title 80
###begin article-title 81
A novel RAB7 mutation associated with ulcero-mutilating neuropathy
###end article-title 81
###begin article-title 82
Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor
###end article-title 82
###begin article-title 83
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis
###end article-title 83
###begin article-title 84
Congenital insensitivity to pain with anhidrosis (CIPA): novel mutations of the TRKA (NTRK1) gene, a putative uniparental disomy, and a linkage of the mutant TRKA and PKLR genes in a family with CIPA and pyruvate kinase deficiency
###end article-title 84
###begin article-title 85
Humoral immunodeficiency in congenital insensitivity to pain with anhidrosis
###end article-title 85
###begin article-title 86
SPTLC1 and RAB7 mutation analysis in dominantly inherited and idiopathic sensory neuropathies
###end article-title 86
###begin article-title 87
A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24
###end article-title 87
###begin article-title 88
[Congenital pain-insensitivity syndrome; a rare indication of the benefit of pain]
###end article-title 88
###begin article-title 89
Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q
###end article-title 89
###begin article-title 90
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates
###end article-title 90
###begin article-title 91
Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system
###end article-title 91
###begin article-title 92
The nerve growth factor: thirty-five years later
###end article-title 92
###begin article-title 93
Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene
###end article-title 93
###begin article-title 94
Familial insensitivity to pain (HSAN V) and a mutation in the NGFB gene. A neurophysiological and pathological study
###end article-title 94
###begin article-title 95
###xml 63 71 <span type="species:ncbi:9606">patients</span>
A novel NGFB point mutation: a phenotype study of heterozygous patients
###end article-title 95
###begin article-title 96
The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily
###end article-title 96
###begin article-title 97
Primer3 on the WWW for general users and for biologist programmers
###end article-title 97
###begin article-title 98
Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF receptor gene, clinical findings, and results of nerve conduction studies
###end article-title 98
###begin article-title 99
Mutations in the nervous system-specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II
###end article-title 99
###begin article-title 100
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia
###end article-title 100
###begin article-title 101
Novel NTRK1 mutations cause hereditary sensory and autonomic neuropathy type IV: demonstration of a founder mutation in the Turkish population
###end article-title 101
###begin article-title 102
Misclassification and linkage of hereditary sensory and autonomic neuropathy type 1 as Charcot-Marie-Tooth disease, type 2B
###end article-title 102
###begin article-title 103
SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I
###end article-title 103
###begin article-title 104
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy
###end article-title 104
###begin article-title 105
Disease mechanisms in hereditary sensory and autonomic neuropathies
###end article-title 105
###begin article-title 106
Recent advances in hereditary sensory and autonomic neuropathies
###end article-title 106
###begin article-title 107
Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV
###end article-title 107
###begin article-title 108
SNPbox: web-based high-throughput primer design from gene to genome
###end article-title 108
###begin article-title 109
novoSNP, a novel computational tool for sequence variation discovery
###end article-title 109
###begin title 110
Abbreviations
###end title 110
###begin p 111
autosomal dominant
###end p 111
###begin p 112
autosomal recessive
###end p 112
###begin p 113
congenital insensitivity to pain and anhidrosis
###end p 113
###begin p 114
Charcot-Marie-Tooth disease
###end p 114
###begin p 115
hereditary motor and sensory neuropathy
###end p 115
###begin p 116
hereditary sensory and autonomic neuropathy
###end p 116
###begin p 117
nerve conduction velocity
###end p 117
###begin p 118
short tandem repeats
###end p 118
###begin p 119
transmembrane domain
###end p 119
###begin p 120
Rab subfamily domain
###end p 120
###begin p 121
conserved domain implicated in binding of phosphate/Mg2+ and guanine binding
###end p 121
###begin p 122
Ras family domain
###end p 122
###begin p 123
protein kinase domain
###end p 123
###begin p 124
autoinhibitory domain
###end p 124
###begin p 125
coiled coil domain
###end p 125
###begin p 126
signal peptide
###end p 126
###begin p 127
cysteine cluster
###end p 127
###begin p 128
leucine rich motif
###end p 128
###begin p 129
immunoglobulin-like domain
###end p 129

